| Year |
Citation |
Score |
| 2020 |
Rusjan PM, Sabioni P, Di Ciano P, Mansouri E, Boileau I, Laveillé A, Capet M, Duvauchelle T, Schwartz JC, Robert P, Le Foll B. Exploring Occupancy of the Histamine H3 Receptor by Pitolisant in Humans Using Positron Emission Tomography. British Journal of Pharmacology. PMID 32293706 DOI: 10.1111/Bph.15067 |
0.406 |
|
| 2019 |
Lecendreux M, Plazzi G, Franco P, Jacqz-Aigrain E, Robert P, Duvauchelle T, Schwartz JC. Pharmacokinetics of pitolisant in children and adolescents with narcolepsy. Sleep Medicine. 66: 220-226. PMID 31978866 DOI: 10.1016/J.Sleep.2019.10.024 |
0.332 |
|
| 2019 |
Setnik B, McDonnell M, Mills C, Scart-Grès C, Robert P, Dayno JM, Schwartz JC. Evaluation of the abuse potential of pitolisant, a selective H3-receptor antagonist/inverse agonist, for the treatment of adult patients with narcolepsy with or without cataplexy. Sleep. PMID 31626696 DOI: 10.1093/Sleep/Zsz252 |
0.415 |
|
| 2019 |
Dauvilliers Y, Arnulf I, Szakacs Z, Leu-Semenescu S, Lecomte I, Scart-Gres C, Lecomte JM, Schwartz JC. Long-term use of pitolisant to treat patients with narcolepsy: Harmony III Study. Sleep. PMID 31529094 DOI: 10.1093/Sleep/Zsz174 |
0.336 |
|
| 2018 |
Thorpy M, Schwartz J, Lecomte J, Caussé C, Dayno JM. 0624 Anticataplectic Efficacy of Pitolisant, the First Potent and Highly Selective Histamine H3-Receptor Antagonist/Inverse Agonist Sleep. 41. DOI: 10.1093/Sleep/Zsy061.623 |
0.48 |
|
| 2017 |
Szakacs Z, Dauvilliers Y, Mikhaylov V, Poverennova I, Krylov S, Jankovic S, Sonka K, Lehert P, Lecomte I, Lecomte JM, Schwartz JC. Safety and efficacy of pitolisant on cataplexy in patients with narcolepsy: a randomised, double-blind, placebo-controlled trial. The Lancet. Neurology. PMID 28129985 DOI: 10.1016/S1474-4422(16)30333-7 |
0.326 |
|
| 2016 |
Levoin N, Labeeuw O, Billot X, Calmels T, Danvy D, Krief S, Berrebi-Bertrand I, Lecomte JM, Schwartz JC, Capet M. Discovery of nanomolar ligands with novel scaffolds for the histamine H4 receptor by virtual screening. European Journal of Medicinal Chemistry. 125: 565-572. PMID 27718472 DOI: 10.1016/J.Ejmech.2016.09.074 |
0.36 |
|
| 2016 |
Labeeuw O, Levoin N, Billot X, Danvy D, Calmels T, Krief S, Ligneau X, Berrebi-Bertrand I, Robert P, Lecomte JM, Schwartz JC, Capet M. Synthesis and evaluation of a 2-benzothiazolylphenylmethyl ether class of histamine H4 receptor antagonists. Bioorganic & Medicinal Chemistry Letters. PMID 27692832 DOI: 10.1016/J.Bmcl.2016.09.049 |
0.415 |
|
| 2016 |
Schwartz JC, Lecomte JM. Clinical trials with H3-receptor inverse agonists: what they tell us about the role of histamine in the human brain. Neuropharmacology. PMID 27060410 DOI: 10.1016/J.Neuropharm.2016.04.006 |
0.427 |
|
| 2015 |
Capet M, Calmels T, Levoin N, Danvy D, Berrebi-Bertrand I, Stark H, Schwartz JC, Lecomte JM. Improving selectivity of dopamine D3 receptor ligands. Bioorganic & Medicinal Chemistry Letters. PMID 26723530 DOI: 10.1016/J.Bmcl.2015.12.068 |
0.427 |
|
| 2015 |
Ierodiakonou D, Zanobetti A, Coull BA, Melly S, Postma DS, Boezen HM, Vonk JM, Williams PV, Shapiro GG, McKone EF, Hallstrand TS, Koenig JQ, Schildcrout JS, Lumley T, Fuhlbrigge AN, ... ... Schwartz J, et al. Ambient air pollution, lung function, and airway responsiveness in asthmatic children. The Journal of Allergy and Clinical Immunology. PMID 26187234 DOI: 10.1016/J.Jaci.2015.05.028 |
0.342 |
|
| 2013 |
Levoin N, Labeeuw O, Krief S, Calmels T, Poupardin-Olivier O, Berrebi-Bertrand I, Lecomte JM, Schwartz JC, Capet M. Determination of the binding mode and interacting amino-acids for dibasic H3 receptor antagonists. Bioorganic & Medicinal Chemistry. 21: 4526-9. PMID 23787288 DOI: 10.1016/J.Bmc.2013.05.035 |
0.396 |
|
| 2013 |
Kasteleijn-Nolst Trenité D, Parain D, Genton P, Masnou P, Schwartz JC, Hirsch E. Efficacy of the histamine 3 receptor (H3R) antagonist pitolisant (formerly known as tiprolisant; BF2.649) in epilepsy: dose-dependent effects in the human photosensitivity model. Epilepsy & Behavior : E&B. 28: 66-70. PMID 23665640 DOI: 10.1016/J.Yebeh.2013.03.018 |
0.327 |
|
| 2013 |
Labeeuw O, Levoin N, Poupardin-Olivier O, Calmels T, Ligneau X, Berrebi-Bertrand I, Robert P, Lecomte JM, Schwartz JC, Capet M. Novel and highly potent histamine H3 receptor ligands. Part 3: an alcohol function to improve the pharmacokinetic profile. Bioorganic & Medicinal Chemistry Letters. 23: 2548-54. PMID 23535326 DOI: 10.1016/J.Bmcl.2013.02.118 |
0.432 |
|
| 2011 |
Levoin N, Calmels T, Krief S, Danvy D, Berrebi-Bertrand I, Lecomte JM, Schwartz JC, Capet M. Homology Model Versus X-ray Structure in Receptor-based Drug Design: A Retrospective Analysis with the Dopamine D3 Receptor. Acs Medicinal Chemistry Letters. 2: 293-7. PMID 24900310 DOI: 10.1021/Ml100288Q |
0.355 |
|
| 2011 |
Levoin N, Labeeuw O, Calmels T, Poupardin-Olivier O, Berrebi-Bertrand I, Lecomte JM, Schwartz JC, Capet M. Novel and highly potent histamine H3 receptor ligands. Part 1: withdrawing of hERG activity. Bioorganic & Medicinal Chemistry Letters. 21: 5378-83. PMID 21802950 DOI: 10.1016/J.Bmcl.2011.07.006 |
0.456 |
|
| 2011 |
Labeeuw O, Levoin N, Poupardin-Olivier O, Calmels T, Ligneau X, Berrebi-Bertrand I, Robert P, Lecomte JM, Schwartz JC, Capet M. Novel and highly potent histamine H3 receptor ligands. Part 2: exploring the cyclohexylamine-based series. Bioorganic & Medicinal Chemistry Letters. 21: 5384-8. PMID 21783360 DOI: 10.1016/J.Bmcl.2011.06.102 |
0.469 |
|
| 2011 |
Schwartz JC. The histamine H3 receptor: from discovery to clinical trials with pitolisant. British Journal of Pharmacology. 163: 713-21. PMID 21615387 DOI: 10.1111/J.1476-5381.2011.01286.X |
0.487 |
|
| 2011 |
Schwartz J, Garbarg M, Pollard H. Histaminergic Transmission in the Brain Comprehensive Physiology. 257-316. DOI: 10.1002/Cphy.Cp010405 |
0.448 |
|
| 2010 |
Walter M, Isensee K, Kottke T, Ligneau X, Camelin JC, Schwartz JC, Stark H. Azole derivatives as histamine H3 receptor antagonists, part 2: C-C and C-S coupled heterocycles. Bioorganic & Medicinal Chemistry Letters. 20: 5883-6. PMID 20727744 DOI: 10.1016/j.bmcl.2010.07.109 |
0.321 |
|
| 2010 |
Jean M, Renault J, Levoin N, Danvy D, Calmels T, Berrebi-Bertrand I, Robert P, Schwartz JC, Lecomte JM, Uriac P, Capet M. Synthesis and evaluation of amides surrogates of dopamine D3 receptor ligands. Bioorganic & Medicinal Chemistry Letters. 20: 5376-9. PMID 20708933 DOI: 10.1016/j.bmcl.2010.07.096 |
0.318 |
|
| 2010 |
Sander K, Kottke T, Hoffend C, Walter M, Weizel L, Camelin JC, Ligneau X, Schneider EH, Seifert R, Schwartz JC, Stark H. First metal-containing histamine H3 receptor ligands. Organic Letters. 12: 2578-81. PMID 20446742 DOI: 10.1021/Ol100419Y |
0.402 |
|
| 2010 |
Sander K, von Coburg Y, Camelin JC, Ligneau X, Rau O, Schubert-Zsilavecz M, Schwartz JC, Stark H. Acidic elements in histamine H(3) receptor antagonists. Bioorganic & Medicinal Chemistry Letters. 20: 1581-4. PMID 20138762 DOI: 10.1016/J.Bmcl.2010.01.089 |
0.418 |
|
| 2009 |
Isensee K, Amon M, Garlapati A, Galaparti A, Ligneau X, Camelin JC, Capet M, Schwartz JC, Stark H. Fluorinated non-imidazole histamine H3 receptor antagonists. Bioorganic & Medicinal Chemistry Letters. 19: 2172-5. PMID 19286376 DOI: 10.1016/j.bmcl.2009.02.110 |
0.303 |
|
| 2009 |
Kuder KJ, Ligneau X, Camelin JC, Lazewska D, Schwartz JC, Schunack W, Stark H, Kieć-Kononowicz K. Diether (substituted) piperidine derivatives as novel, histamine H3 receptor ligands. Inflammation Research : Official Journal of the European Histamine Research Society ... [Et Al.]. 58: 47-8. PMID 19266264 DOI: 10.1007/s00011-009-2002-6 |
0.334 |
|
| 2009 |
Isensee K, Amon M, Garlapati A, Ligneau X, Camelin JC, Capet M, Schwartz JC, Stark H. Corrigendum to "Fluorinated non-imidazole histamine H3 receptor antagonists" [Bioorg. Med. Chem. Lett. 19 (2009) 2172] (DOI:10.1016/j.bmcl.2009.02.110) Bioorganic and Medicinal Chemistry Letters. 19: 3348. DOI: 10.1016/j.bmcl.2009.02.127 |
0.365 |
|
| 2008 |
Åazewska D, Kuder K, Ligneau X, Schwartz JC, Schunack W, Stark H, Kieć-Kononowicz K. Piperidine variations in search for non-imidazole histamine H(3) receptor ligands. Bioorganic & Medicinal Chemistry. 16: 8729-36. PMID 18774720 DOI: 10.1016/J.Bmc.2008.07.071 |
0.443 |
|
| 2007 |
Saur O, Hackling AE, Perachon S, Schwartz JC, Sokoloff P, Stark H. N-(4-(4-(2-Halogenophenyl)piperazin-1-yl)butyl) substituted cinnamoyl amide derivatives as dopamine D2 and D3 receptor ligands. Archiv Der Pharmazie. 340: 178-84. PMID 17405129 DOI: 10.1002/ardp.200600196 |
0.32 |
|
| 2007 |
Amon M, Ligneau X, Camelin JC, Berrebi-Bertrand I, Schwartz JC, Stark H. Highly potent fluorescence-tagged nonimidazole histamine H3 receptor ligands. Chemmedchem. 2: 708-16. PMID 17361979 DOI: 10.1002/Cmdc.200600270 |
0.444 |
|
| 2007 |
Ligneau X, Landais L, Perrin D, Piriou J, Uguen M, Denis E, Robert P, Parmentier R, Anaclet C, Lin JS, Burban A, Arrang JM, Schwartz JC. Brain histamine and schizophrenia: potential therapeutic applications of H3-receptor inverse agonists studied with BF2.649. Biochemical Pharmacology. 73: 1215-24. PMID 17343831 DOI: 10.1016/J.Bcp.2007.01.023 |
0.461 |
|
| 2007 |
Ligneau X, Perrin D, Landais L, Camelin JC, Calmels TP, Berrebi-Bertrand I, Lecomte JM, Parmentier R, Anaclet C, Lin JS, Bertaina-Anglade V, la Rochelle CD, d'Aniello F, Rouleau A, Gbahou F, ... ... Schwartz JC, et al. BF2.649 [1-{3-[3-(4-Chlorophenyl)propoxy]propyl}piperidine, hydrochloride], a nonimidazole inverse agonist/antagonist at the human histamine H3 receptor: Preclinical pharmacology. The Journal of Pharmacology and Experimental Therapeutics. 320: 365-75. PMID 17005916 DOI: 10.1124/Jpet.106.111039 |
0.378 |
|
| 2006 |
Faucard R, Armand V, Héron A, Cochois V, Schwartz JC, Arrang JM. N-methyl-D-aspartate receptor antagonists enhance histamine neuron activity in rodent brain. Journal of Neurochemistry. 98: 1487-96. PMID 16923161 DOI: 10.1111/J.1471-4159.2006.04002.X |
0.42 |
|
| 2006 |
Åazewska D, Ligneau X, Schwartz JC, Schunack W, Stark H, Kieć-Kononowicz K. Ether derivatives of 3-piperidinopropan-1-ol as non-imidazole histamine H3 receptor antagonists. Bioorganic & Medicinal Chemistry. 14: 3522-9. PMID 16466921 DOI: 10.1016/J.Bmc.2006.01.013 |
0.455 |
|
| 2006 |
Amon M, Ligneau X, Schwartz JC, Stark H. Fluorescent non-imidazole histamine H3 receptor ligands with nanomolar affinities. Bioorganic & Medicinal Chemistry Letters. 16: 1938-40. PMID 16434192 DOI: 10.1016/j.bmcl.2005.12.084 |
0.321 |
|
| 2005 |
Apelt J, Grassmann S, Ligneau X, Pertz HH, Ganellin CR, Arrang JM, Schwartz JC, Schunack W, Stark H. Search for histamine H3 receptor antagonists with combined inhibitory potency at Ntau-methyltransferase: ether derivatives. Die Pharmazie. 60: 97-106. PMID 15739896 |
0.37 |
|
| 2005 |
Heidler P, Zohrabi-Kalantari V, Calmels T, Capet M, Berrebi-Bertrand I, Schwartz JC, Stark H, Link A. Parallel synthesis and dopamine D3/D2 receptor screening of novel {4-[4-(2-methoxyphenyl)piperazin-1-yl]butyl}carboxamides. Bioorganic & Medicinal Chemistry. 13: 2009-14. PMID 15727854 DOI: 10.1016/J.Bmc.2005.01.018 |
0.467 |
|
| 2005 |
Costentin J, Marçais H, Protais P, Schwartz JC. Tolerance to hypokinesia elicited by dopamine agonists in mice: hyposensitization of autoreceptors? Life Sciences. 20: 883-6. PMID 15714774 DOI: 10.1016/0024-3205(77)90041-8 |
0.558 |
|
| 2004 |
Grassmann S, Apelt J, Ligneau X, Pertz HH, Arrang JM, Ganellin CR, Schwartz JC, Schunack W, Stark H. Search for histamine H(3) receptor ligands with combined inhibitory potency at histamine N-methyltransferase: omega-piperidinoalkanamine derivatives. Archiv Der Pharmazie. 337: 533-45. PMID 15476285 DOI: 10.1002/Ardp.200400897 |
0.433 |
|
| 2004 |
Rouleau A, Héron A, Cochois V, Pillot C, Schwartz JC, Arrang JM. Cloning and expression of the mouse histamine H3 receptor: evidence for multiple isoforms. Journal of Neurochemistry. 90: 1331-8. PMID 15341517 DOI: 10.1111/J.1471-4159.2004.02606.X |
0.503 |
|
| 2004 |
Mach UR, Hackling AE, Perachon S, Ferry S, Wermuth CG, Schwartz JC, Sokoloff P, Stark H. Development of novel 1,2,3,4-tetrahydroisoquinoline derivatives and closely related compounds as potent and selective dopamine D3 receptor ligands. Chembiochem : a European Journal of Chemical Biology. 5: 508-18. PMID 15185375 DOI: 10.1002/Cbic.200300784 |
0.462 |
|
| 2004 |
Pelloux-Léon N, Fkyerat A, Piripitsi A, Tertiuk W, Schunack W, Stark H, Garbarg M, Ligneau X, Arrang JM, Schwartz JC, Ganellin CR. Meta-substituted aryl(thio)ethers as potent partial agonists (or antagonists) for the histamine H3 receptor lacking a nitrogen atom in the side chain. Journal of Medicinal Chemistry. 47: 3264-74. PMID 15163206 DOI: 10.1021/Jm031141P |
0.333 |
|
| 2004 |
Meier G, Krause M, Hüls A, Ligneau X, Pertz HH, Arrang JM, Ganellin CR, Schwartz JC, Schunack W, Stark H. 4-(omega-(alkyloxy)alkyl)-1H-imidazole derivatives as histamine H(3) receptor antagonists/agonists. Journal of Medicinal Chemistry. 47: 2678-87. PMID 15115409 DOI: 10.1021/Jm031065Q |
0.463 |
|
| 2004 |
Mikó T, Ligneau X, Pertz HH, Arrang JM, Ganellin CR, Schwartz JC, Schunack W, Stark H. Structural variations of 1-(4-(phenoxymethyl)benzyl)piperidines as nonimidazole histamine H3 receptor antagonists. Bioorganic & Medicinal Chemistry. 12: 2727-36. PMID 15110854 DOI: 10.1016/J.Bmc.2004.03.009 |
0.451 |
|
| 2004 |
Guillin O, Griffon N, Diaz J, Le Foll B, Bezard E, Gross C, Lammers C, Stark H, Carroll P, Schwartz JC, Sokoloff P. Brain-derived neurotrophic factor and the plasticity of the mesolimbic dopamine pathway. International Review of Neurobiology. 59: 425-44. PMID 15006497 DOI: 10.1016/S0074-7742(04)59016-5 |
0.308 |
|
| 2003 |
Gbahou F, Rouleau A, Morisset S, Parmentier R, Crochet S, Lin JS, Ligneau X, Tardivel-Lacombe J, Stark H, Schunack W, Ganellin CR, Schwartz JC, Arrang JM. Protean agonism at histamine H3 receptors in vitro and in vivo. Proceedings of the National Academy of Sciences of the United States of America. 100: 11086-91. PMID 12960366 DOI: 10.1073/Pnas.1932276100 |
0.451 |
|
| 2003 |
Hackling A, Ghosh R, Perachon S, Mann A, Höltje HD, Wermuth CG, Schwartz JC, Sippl W, Sokoloff P, Stark H. N-(omega-(4-(2-methoxyphenyl)piperazin-1-yl)alkyl)carboxamides as dopamine D2 and D3 receptor ligands. Journal of Medicinal Chemistry. 46: 3883-99. PMID 12930150 DOI: 10.1021/Jm030836N |
0.435 |
|
| 2003 |
Leriche L, Schwartz JC, Sokoloff P. The dopamine D3 receptor mediates locomotor hyperactivity induced by NMDA receptor blockade. Neuropharmacology. 45: 174-81. PMID 12842123 DOI: 10.1016/S0028-3908(03)00145-X |
0.461 |
|
| 2003 |
Schwartz JC, Morisset S, Rouleau A, Ligneau X, Gbahou F, Tardivel-Lacombe J, Stark H, Schunack W, Ganellin CR, Arrang JM. Therapeutic implications of constitutive activity of receptors: the example of the histamine H3 receptor. Journal of Neural Transmission. Supplementum. 1-16. PMID 12830926 |
0.395 |
|
| 2003 |
Grassmann S, Apelt J, Sippl W, Ligneau X, Pertz HH, Zhao YH, Arrang JM, Ganellin CR, Schwartz JC, Schunack W, Stark H. Imidazole derivatives as a novel class of hybrid compounds with inhibitory histamine N-methyltransferase potencies and histamine hH3 receptor affinities. Bioorganic & Medicinal Chemistry. 11: 2163-74. PMID 12713826 DOI: 10.1016/S0968-0896(03)00120-2 |
0.474 |
|
| 2003 |
Mikó T, Ligneau X, Pertz HH, Ganellin CR, Arrang JM, Schwartz JC, Schunack W, Stark H. Novel nonimidazole histamine H3 receptor antagonists: 1-(4-(phenoxymethyl)benzyl)piperidines and related compounds. Journal of Medicinal Chemistry. 46: 1523-30. PMID 12672253 DOI: 10.1021/Jm021084K |
0.483 |
|
| 2003 |
Pillot C, Héron A, Schwartz JC, Arrang JM. Ciproxifan, a histamine H3-receptor antagonist/inverse agonist, modulates the effects of methamphetamine on neuropeptide mRNA expression in rat striatum. The European Journal of Neuroscience. 17: 307-14. PMID 12542667 DOI: 10.1046/J.1460-9568.2003.02422.X |
0.453 |
|
| 2002 |
Pillot C, Heron A, Cochois V, Tardivel-Lacombe J, Ligneau X, Schwartz JC, Arrang JM. A detailed mapping of the histamine H(3) receptor and its gene transcripts in rat brain. Neuroscience. 114: 173-93. PMID 12207964 DOI: 10.1016/S0306-4522(02)00135-5 |
0.371 |
|
| 2002 |
Sasse A, Ligneau X, Rouleau A, Elz S, Ganellin CR, Arrang JM, Schwartz JC, Schunack W, Stark H. Influence of bulky substituents on histamine h(3) receptor agonist/antagonist properties. Journal of Medicinal Chemistry. 45: 4000-10. PMID 12190321 DOI: 10.1021/Jm020910M |
0.459 |
|
| 2002 |
Pillot C, Ortiz J, Héron A, Ridray S, Schwartz JC, Arrang JM. Ciproxifan, a histamine H3-receptor antagonist/inverse agonist, potentiates neurochemical and behavioral effects of haloperidol in the rat. The Journal of Neuroscience : the Official Journal of the Society For Neuroscience. 22: 7272-80. PMID 12177222 DOI: 10.1523/Jneurosci.22-16-07272.2002 |
0.502 |
|
| 2002 |
Le Foll B, Francès H, Diaz J, Schwartz JC, Sokoloff P. Role of the dopamine D3 receptor in reactivity to cocaine-associated cues in mice. The European Journal of Neuroscience. 15: 2016-26. PMID 12099907 DOI: 10.1046/J.1460-9568.2002.02049.X |
0.302 |
|
| 2002 |
Meier G, Ligneau X, Pertz HH, Ganellin CR, Schwartz JC, Schunack W, Stark H. Piperidino-hydrocarbon compounds as novel non-imidazole histamine H(3)-receptor antagonists. Bioorganic & Medicinal Chemistry. 10: 2535-42. PMID 12057642 DOI: 10.1016/S0968-0896(02)00115-3 |
0.4 |
|
| 2002 |
Trottier S, Chotard C, Traiffort E, Unmehopa U, Fisser B, Swaab DF, Schwartz JC. Co-localization of histamine with GABA but not with galanin in the human tuberomamillary nucleus. Brain Research. 939: 52-64. PMID 12020851 DOI: 10.1016/S0006-8993(02)02546-5 |
0.579 |
|
| 2002 |
Wiecek M, Kieć-Kononowicz K, Sasse A, Ligneau X, Schwartz JC, Schunack W, Stark H. Impact of lipophilicity on the pharmacological properties of histamine H3-receptor antagonists of the cycloalkyl carbamate class. Inflammation Research : Official Journal of the European Histamine Research Society ... [Et Al.]. 51: S71-2. PMID 12013417 DOI: 10.1007/PL00000274 |
0.351 |
|
| 2002 |
Grassmann S, Sadek B, Ligneau X, Elz S, Ganellin CR, Arrang JM, Schwartz JC, Stark H, Schunack W. Progress in the proxifan class: heterocyclic congeners as novel potent and selective histamine H(3)-receptor antagonists. European Journal of Pharmaceutical Sciences : Official Journal of the European Federation For Pharmaceutical Sciences. 15: 367-78. PMID 11988398 DOI: 10.1016/S0928-0987(02)00024-6 |
0.504 |
|
| 2002 |
Chotard C, Ouimet T, Morisset S, Sahm U, Schwartz JC, Trottier S. Effects of histamine H3 receptor agonist and antagonist on histamine co-transmitter expression in rat brain. Journal of Neural Transmission (Vienna, Austria : 1996). 109: 293-306. PMID 11956952 DOI: 10.1007/s007020200024 |
0.345 |
|
| 2002 |
Apelt J, Ligneau X, Pertz HH, Arrang JM, Ganellin CR, Schwartz JC, Schunack W, Stark H. Development of a new class of nonimidazole histamine H(3) receptor ligands with combined inhibitory histamine N-methyltransferase activity. Journal of Medicinal Chemistry. 45: 1128-41. PMID 11855993 DOI: 10.1021/Jm0110845 |
0.471 |
|
| 2002 |
Rouleau A, Ligneau X, Tardivel-Lacombe J, Morisset S, Gbahou F, Schwartz JC, Arrang JM. Histamine H3-receptor-mediated [35S]GTP gamma[S] binding: evidence for constitutive activity of the recombinant and native rat and human H3 receptors. British Journal of Pharmacology. 135: 383-92. PMID 11815373 DOI: 10.1038/sj.bjp.0704490 |
0.347 |
|
| 2002 |
Morisset S, Pilon C, Tardivel-Lacombe J, Weinstein D, Rostene W, Betancur C, Sokoloff P, Schwartz JC, Arrang JM. Acute and chronic effects of methamphetamine on tele-methylhistamine levels in mouse brain: selective involvement of the D(2) and not D(3) receptor. The Journal of Pharmacology and Experimental Therapeutics. 300: 621-8. PMID 11805225 DOI: 10.1124/jpet.300.2.621 |
0.337 |
|
| 2001 |
Sokoloff P, Le Foll B, Perachon S, Bordet R, Ridray S, Schwartz JC. The dopamine D3 receptor and drug addiction. Neurotoxicity Research. 3: 433-41. PMID 14715457 DOI: 10.1007/Bf03033202 |
0.345 |
|
| 2001 |
Stark H, Arrang JM, Ligneau X, Garbarg M, Ganellin CR, Schwartz JC, Schunack W. The histamine H3 receptor and its ligands. Progress in Medicinal Chemistry. 38: 279-308. PMID 11774797 DOI: 10.1016/S0079-6468(08)70096-1 |
0.477 |
|
| 2001 |
Schwartz JC, Morisset S, Rouleau A, Tardivel-Lacombe J, Gbahou F, Ligneau X, Héron A, Sasse A, Stark H, Schunack W, Ganellin RC, Arrang JM. Application of genomics to drug design: the example of the histamine H3 receptor. European Neuropsychopharmacology : the Journal of the European College of Neuropsychopharmacology. 11: 441-8. PMID 11704421 DOI: 10.1016/S0924-977X(01)00121-3 |
0.475 |
|
| 2001 |
Héron A, Rouleau A, Cochois V, Pillot C, Schwartz JC, Arrang JM. Expression analysis of the histamine H(3) receptor in developing rat tissues. Mechanisms of Development. 105: 167-73. PMID 11429293 DOI: 10.1016/S0925-4773(01)00389-6 |
0.347 |
|
| 2001 |
Meier G, Apelt J, Reichert U, Grassmann S, Ligneau X, Elz S, Leurquin F, Ganellin CR, Schwartz JC, Schunack W, Stark H. Influence of imidazole replacement in different structural classes of histamine H(3)-receptor antagonists. European Journal of Pharmaceutical Sciences : Official Journal of the European Federation For Pharmaceutical Sciences. 13: 249-59. PMID 11384847 DOI: 10.1016/S0928-0987(01)00106-3 |
0.4 |
|
| 2001 |
Guillin O, Diaz J, Carroll P, Griffon N, Schwartz JC, Sokoloff P. BDNF controls dopamine D3 receptor expression and triggers behavioural sensitization. Nature. 411: 86-9. PMID 11333982 DOI: 10.1038/35075076 |
0.383 |
|
| 2001 |
Stark H, Sippl W, Ligneau X, Arrang JM, Ganellin CR, Schwartz JC, Schunack W. Different antagonist binding properties of human and rat histamine H3 receptors. Bioorganic & Medicinal Chemistry Letters. 11: 951-4. PMID 11294398 DOI: 10.1016/S0960-894X(01)00090-7 |
0.489 |
|
| 2001 |
Sasse A, Ligneau X, Sadek B, Elz S, Pertz HH, Ganellin CR, Arrang JM, Schwartz JC, Schunack W, Stark H. Benzophenone derivatives and related compounds as potent histamine H3-receptor antagonists and potential PET/SPECT ligands. Archiv Der Pharmazie. 334: 45-52. PMID 11268774 DOI: 10.1002/1521-4184(200102)334:2<45::AID-ARDP45>3.0.CO;2-2 |
0.349 |
|
| 2001 |
Tardivel-Lacombe J, Morisset S, Gbahou F, Schwartz JC, Arrang JM. Chromosomal mapping and organization of the human histamine H3 receptor gene. Neuroreport. 12: 321-4. PMID 11209943 DOI: 10.1097/00001756-200102120-00028 |
0.33 |
|
| 2001 |
Stark H, Krause M, Rouleau A, Garbarg M, Schwartz JC, Schunack W. Enzyme-catalyzed prodrug approaches for the histamine H3-receptor agonist (R)-alpha-methylhistamine. Bioorganic & Medicinal Chemistry. 9: 191-8. PMID 11197341 DOI: 10.1016/S0968-0896(00)00237-6 |
0.369 |
|
| 2001 |
Morisset S, Sasse A, Gbahou F, Héron A, Ligneau X, Tardivel-Lacombe J, Schwartz JC, Arrang JM. The rat H3 receptor: gene organization and multiple isoforms. Biochemical and Biophysical Research Communications. 280: 75-80. PMID 11162480 DOI: 10.1006/Bbrc.2000.4073 |
0.411 |
|
| 2000 |
Kieć-Kononowicz K, Wiecek M, Sasse A, Ligneau X, Elz S, Ganellin CR, Schwartz JC, Stark H, Schunack W. Importance of the lipophilic group in carbamates having histamine H3-receptor antagonist activity. Die Pharmazie. 55: 349-55. PMID 11828613 |
0.38 |
|
| 2000 |
Morisset S, Rouleau A, Ligneau X, Gbahou F, Tardivel-Lacombe J, Stark H, Schunack W, Ganellin CR, Schwartz JC, Arrang JM. High constitutive activity of native H3 receptors regulates histamine neurons in brain. Nature. 408: 860-4. PMID 11130725 DOI: 10.1038/35048583 |
0.376 |
|
| 2000 |
Diaz J, Pilon C, Le Foll B, Gros C, Triller A, Schwartz JC, Sokoloff P. Dopamine D3 receptors expressed by all mesencephalic dopamine neurons. The Journal of Neuroscience : the Official Journal of the Society For Neuroscience. 20: 8677-84. PMID 11102473 DOI: 10.1523/Jneurosci.20-23-08677.2000 |
0.376 |
|
| 2000 |
Stark H, Ligneau X, Sadek B, Ganellin CR, Arrang JM, Schwartz JC, Schunack W. Analogues and derivatives of ciproxifan, a novel prototype for generating potent histamine H3-receptor antagonists. Bioorganic & Medicinal Chemistry Letters. 10: 2379-82. PMID 11055360 DOI: 10.1016/S0960-894X(00)00473-X |
0.48 |
|
| 2000 |
Stark H, Sadek B, Krause M, Hüls A, Ligneau X, Ganellin CR, Arrang JM, Schwartz JC, Schunack W. Novel histamine H(3)-receptor antagonists with carbonyl-substituted 4-(3-(phenoxy)propyl)-1H-imidazole structures like ciproxifan and related compounds. Journal of Medicinal Chemistry. 43: 3987-94. PMID 11052804 DOI: 10.1021/jm000966l |
0.361 |
|
| 2000 |
Sasse A, Sadek B, Ligneau X, Elz S, Pertz HH, Luger P, Ganellin CR, Arrang JM, Schwartz JC, Schunack W, Stark H. New histamine H(3)-receptor ligands of the proxifan series: imoproxifan and other selective antagonists with high oral in vivo potency. Journal of Medicinal Chemistry. 43: 3335-43. PMID 10966752 DOI: 10.1021/Jm000971P |
0.376 |
|
| 2000 |
Lammers CH, Diaz J, Schwartz JC, Sokoloff P. Selective increase of dopamine D3 receptor gene expression as a common effect of chronic antidepressant treatments. Molecular Psychiatry. 5: 378-88. PMID 10889548 |
0.314 |
|
| 2000 |
Bordet R, Ridray S, Schwartz JC, Sokoloff P. Involvement of the direct striatonigral pathway in levodopa-induced sensitization in 6-hydroxydopamine-lesioned rats. The European Journal of Neuroscience. 12: 2117-23. PMID 10886351 DOI: 10.1046/J.1460-9568.2000.00089.X |
0.475 |
|
| 2000 |
Sasse A, Stark H, Ligneau X, Elz S, Reidemeister S, Ganellin CR, Schwartz JC, Schunack W. (Partial) agonist/antagonist properties of novel diarylalkyl carbamates on histamine H3 receptors. Bioorganic & Medicinal Chemistry. 8: 1139-49. PMID 10882024 DOI: 10.1016/S0968-0896(00)00050-X |
0.463 |
|
| 2000 |
Ouimet T, Facchinetti P, Rose C, Bonhomme MC, Gros C, Schwartz JC, Tanja O. Neprilysin II: A putative novel metalloprotease and its isoforms in CNS and testis. Biochemical and Biophysical Research Communications. 271: 565-70. PMID 10814502 DOI: 10.1006/Bbrc.2000.2664 |
0.333 |
|
| 2000 |
Tardivel-Lacombe J, Rouleau A, Héron A, Morisset S, Pillot C, Cochois V, Schwartz JC, Arrang JM. Cloning and cerebral expression of the guinea pig histamine H3 receptor: evidence for two isoforms. Neuroreport. 11: 755-9. PMID 10757514 DOI: 10.1097/00001756-200003200-00020 |
0.47 |
|
| 2000 |
Reidemeister S, Stark H, Ligneau X, Ganellin CR, Schwartz JC, Schunack W. Substituted N-phenylcarbamates as histamine H3 receptor antagonists with improved in vivo potency. Die Pharmazie. 55: 83-6. PMID 10723763 |
0.392 |
|
| 2000 |
Schwartz JC, Diaz J, Pilon C, Sokoloff P. Possible implications of the dopamine D(3) receptor in schizophrenia and in antipsychotic drug actions. Brain Research. Brain Research Reviews. 31: 277-87. PMID 10719154 DOI: 10.1016/S0165-0173(99)00043-0 |
0.438 |
|
| 2000 |
Perachon S, Betancur C, Pilon C, Rostène W, Schwartz JC, Sokoloff P. Role of dopamine D3 receptors in thermoregulation: a reappraisal. Neuroreport. 11: 221-5. PMID 10683862 DOI: 10.1097/00001756-200001170-00044 |
0.449 |
|
| 2000 |
Morisset S, Traiffort E, Arrang JM, Schwartz JC. Changes in histamine H3 receptor responsiveness in mouse brain. Journal of Neurochemistry. 74: 339-46. PMID 10617138 DOI: 10.1046/J.1471-4159.2000.0740339.X |
0.684 |
|
| 1999 |
Sasse A, Stark H, Reidemeister S, Hüls A, Elz S, Ligneau X, Ganellin CR, Schwartz JC, Schunack W. Novel partial agonists for the histamine H(3) receptor with high in vitro and in vivo activity. Journal of Medicinal Chemistry. 42: 4269-74. PMID 10514298 DOI: 10.1021/Jm991068W |
0.409 |
|
| 1999 |
Pilla M, Perachon S, Sautel F, Garrido F, Mann A, Wermuth CG, Schwartz JC, Everitt BJ, Sokoloff P. Selective inhibition of cocaine-seeking behaviour by a partial dopamine D3 receptor agonist. Nature. 400: 371-5. PMID 10432116 DOI: 10.1038/22560 |
0.369 |
|
| 1999 |
Allard J, Barron S, Trottier S, Cervera P, Daumas-Duport C, Leguern E, Brice A, Schwartz JC, Sokoloff P. Edg-2 in myelin-forming cells: isoforms, genomic mapping, and exclusion in Charcot-Marie-Tooth disease. Glia. 26: 176-85. PMID 10384882 DOI: 10.1002/(Sici)1098-1136(199904)26:2<176::Aid-Glia8>3.0.Co;2-K |
0.34 |
|
| 1999 |
Drutel G, Héron A, Kathmann M, Gros C, Macé S, Plotkine M, Schwartz JC, Arrang JM. ARNT2, a transcription factor for brain neuron survival? The European Journal of Neuroscience. 11: 1545-53. PMID 10215907 DOI: 10.1046/J.1460-9568.1999.00562.X |
0.303 |
|
| 1999 |
Perachon S, Schwartz JC, Sokoloff P. Functional potencies of new antiparkinsonian drugs at recombinant human dopamine D1, D2 and D3 receptors. European Journal of Pharmacology. 366: 293-300. PMID 10082211 |
0.313 |
|
| 1999 |
Sasse A, Kiec-Kononowicz K, Stark H, Motyl M, Reidemeister S, Ganellin CR, Ligneau X, Schwartz JC, Schunack W. Development of chiral N-alkylcarbamates as new leads for potent and selective H3-receptor antagonists: synthesis, capillary electrophoresis, and in vitro and oral in vivo activity. Journal of Medicinal Chemistry. 42: 593-600. PMID 10052966 DOI: 10.1021/jm9804376 |
0.392 |
|
| 1999 |
Morisset S, Sahm UG, Traiffort E, Tardivel-Lacombe J, Arrang JM, Schwartz JC. Atypical neuroleptics enhance histamine turnover in brain via 5-Hydroxytryptamine2A receptor blockade. The Journal of Pharmacology and Experimental Therapeutics. 288: 590-6. PMID 9918563 |
0.708 |
|
| 1999 |
Matzanke N, Löwe W, Perachon S, Sokoloff P, Schwartz J, Stark H. Heterocyclic congeners of PD 128,907 with a partially hydrogenated benzomorpholine moiety as potential dopamine D3-receptor ligands European Journal of Medicinal Chemistry. 34: 791-798. DOI: 10.1016/S0223-5234(99)00213-5 |
0.427 |
|
| 1998 |
Sokoloff P, Diaz J, Bordet R, Griffon N, Perachon S, Pilon C, Ridray S, Schwartz JC. [Function and therapeutic potential of the dopamine D3 receptor]. Comptes Rendus Des Sã©Ances De La Sociã©Tã© De Biologie Et De Ses Filiales. 192: 1111-25. PMID 10101607 |
0.358 |
|
| 1998 |
Ganellin CR, Leurquin F, Piripitsi A, Arrang JM, Garbarg M, Ligneau X, Schunack W, Schwartz JC. Synthesis of potent non-imidazole histamine H3-receptor antagonists. Archiv Der Pharmazie. 331: 395-404. PMID 9923195 DOI: 10.1002/(SICI)1521-4184(199812)331:12<395::AID-ARDP395>3.0.CO;2-7 |
0.317 |
|
| 1998 |
Stark H, Ligneau X, Arrang JM, Schwartz JC, Schunack W. General construction pattern of histamine H3-receptor antagonists: change of a paradigm. Bioorganic & Medicinal Chemistry Letters. 8: 2011-6. PMID 9873477 |
0.376 |
|
| 1998 |
Krause M, Ligneau X, Stark H, Garbarg M, Schwartz JC, Schunack W. 4-Alkynylphenyl imidazolylpropyl ethers as selective histamine H3-receptor antagonists with high oral central nervous system activity. Journal of Medicinal Chemistry. 41: 4171-6. PMID 9767653 DOI: 10.1021/Jm9802970 |
0.484 |
|
| 1998 |
Ridray S, Griffon N, Mignon V, Souil E, Carboni S, Diaz J, Schwartz JC, Sokoloff P. Coexpression of dopamine D1 and D3 receptors in islands of Calleja and shell of nucleus accumbens of the rat: opposite and synergistic functional interactions. The European Journal of Neuroscience. 10: 1676-86. PMID 9751140 DOI: 10.1046/J.1460-9568.1998.00173.X |
0.409 |
|
| 1998 |
Stark H, Hüls A, Ligneau X, Purand K, Pertz H, Arrang JM, Schwartz JC, Schunack W. Development of FUB 181, a selective histamine H3-receptor antagonist of high oral in vivo potency with 4-(omega-(arylalkyloxy)alkyl)-1H-imidazole structure. Archiv Der Pharmazie. 331: 211-8. PMID 9713254 DOI: 10.1002/(Sici)1521-4184(199806)331:6<211::Aid-Ardp211>3.0.Co;2-P |
0.459 |
|
| 1998 |
Schwartz JC, Diaz J, Bordet R, Griffon N, Perachon S, Pilon C, Ridray S, Sokoloff P. Functional implications of multiple dopamine receptor subtypes: the D1/D3 receptor coexistence. Brain Research. Brain Research Reviews. 26: 236-42. PMID 9651537 DOI: 10.1016/S0165-0173(97)00046-5 |
0.452 |
|
| 1998 |
Suzuki M, Hurd YL, Sokoloff P, Schwartz JC, Sedvall G. D3 dopamine receptor mRNA is widely expressed in the human brain. Brain Research. 779: 58-74. PMID 9473588 DOI: 10.1016/S0006-8993(97)01078-0 |
0.416 |
|
| 1998 |
Bruins-Slot L, Gorwood P, Bouvard M, Blot P, Adès J, Feingold J, Schwartz JC, Mouren-Siméoni MC. Lack of association between anorexia nervosa and D3 dopamine receptor gene. Biological Psychiatry. 43: 76-8. PMID 9442347 DOI: 10.1016/S0006-3223(97)00199-6 |
0.358 |
|
| 1997 |
Hill SJ, Ganellin CR, Timmerman H, Schwartz JC, Shankley NP, Young JM, Schunack W, Levi R, Haas HL. International Union of Pharmacology. XIII. Classification of histamine receptors. Pharmacological Reviews. 49: 253-78. PMID 9311023 |
0.301 |
|
| 1997 |
Vizuete ML, Traiffort E, Bouthenet ML, Ruat M, Souil E, Tardivel-Lacombe J, Schwartz JC. Detailed mapping of the histamine H2 receptor and its gene transcripts in guinea-pig brain. Neuroscience. 80: 321-43. PMID 9284338 DOI: 10.1016/S0306-4522(97)00010-9 |
0.687 |
|
| 1997 |
Stark H, Hüls A, Ligneau X, Arrang JM, Schwartz JC, Schunack W. Search for novel leads for histamine H3-receptor antagonists: oxygen-containing derivatives. Die Pharmazie. 52: 495-500. PMID 9266588 |
0.403 |
|
| 1997 |
Stark H, Ligneau X, Lipp R, Arrang JM, Schwartz JC, Schunack W. Search for novel leads for histamine H3-receptor antagonists: amine derivatives. Die Pharmazie. 52: 419-23. PMID 9260265 |
0.392 |
|
| 1997 |
Diaz J, Ridray S, Mignon V, Griffon N, Schwartz JC, Sokoloff P. Selective expression of dopamine D3 receptor mRNA in proliferative zones during embryonic development of the rat brain. The Journal of Neuroscience : the Official Journal of the Society For Neuroscience. 17: 4282-92. PMID 9151745 DOI: 10.1523/Jneurosci.17-11-04282.1997 |
0.368 |
|
| 1997 |
Bordet R, Ridray S, Carboni S, Diaz J, Sokoloff P, Schwartz JC. Induction of dopamine D3 receptor expression as a mechanism of behavioral sensitization to levodopa. Proceedings of the National Academy of Sciences of the United States of America. 94: 3363-7. PMID 9096399 DOI: 10.1073/Pnas.94.7.3363 |
0.474 |
|
| 1997 |
Griffon N, Pilon C, Sautel F, Schwartz JC, Sokoloff P. Two intracellular signaling pathways for the dopamine D3 receptor: opposite and synergistic interactions with cyclic AMP. Journal of Neurochemistry. 68: 1-9. PMID 8978703 DOI: 10.1046/J.1471-4159.1997.68010001.X |
0.479 |
|
| 1996 |
Griffon N, Pilon C, Sautel F, Schwartz JC, Sokoloff P. Antipsychotics with inverse agonist activity at the dopamine D3 receptor. Journal of Neural Transmission (Vienna, Austria : 1996). 103: 1163-75. PMID 9013403 |
0.385 |
|
| 1996 |
Morisset S, Traiffort E, Schwartz JC. Inhibition of histamine versus acetylcholine metabolism as a mechanism of tacrine activity. European Journal of Pharmacology. 315: R1-2. PMID 8960873 DOI: 10.1016/S0014-2999(96)00738-8 |
0.696 |
|
| 1996 |
Hüls A, Purand K, Stark H, Reidemeister S, Ligneau X, Arrang JM, Schwartz JC, Schunack W. Novel histamine H3-receptor antagonists with benzyl ether structure or related moieties: synthesis and structure-activity relationships. Archiv Der Pharmazie. 329: 379-85. PMID 8915097 DOI: 10.1002/Ardp.19963290802 |
0.488 |
|
| 1996 |
Héron A, Traiffort E, Allix M, Dimitriadou V, Schwartz JC. Prodynorphin mRNA expression in the rat dentate gyrus after cerebral ischemia. Neuropeptides. 30: 355-8. PMID 8914861 DOI: 10.1016/S0143-4179(96)90024-4 |
0.631 |
|
| 1996 |
Soldani G, Garbarg M, Intorre L, Bertini S, Rouleau A, Schwartz JC. Modulation of pentagastrin-induced histamine release by histamine H3 receptors in the dog. Scandinavian Journal of Gastroenterology. 31: 631-8. PMID 8819209 |
0.302 |
|
| 1996 |
Drutel G, Kathmann M, Heron A, Schwartz JC, Arrang JM. Cloning and selective expression in brain and kidney of ARNT2 homologous to the Ah receptor nuclear translocator (ARNT). Biochemical and Biophysical Research Communications. 225: 333-9. PMID 8753765 DOI: 10.1006/Bbrc.1996.1176 |
0.385 |
|
| 1996 |
Stark H, Purand K, Ligneau X, Rouleau A, Arrang JM, Garbarg M, Schwartz JC, Schunack W. Novel carbamates as potent histamine H3 receptor antagonists with high in vitro and oral in vivo activity. Journal of Medicinal Chemistry. 39: 1157-63. PMID 8676353 DOI: 10.1021/Jm9507688 |
0.496 |
|
| 1996 |
Griffon N, Sautel F, Pilon C, Lévesque D, Sokoloff P, Schwartz JC, Diaz J, Simon P, Costentin J, Mann A, Wermuth CG. Functional models for the dopamine D3 receptor. Biochemical Society Transactions. 24: 193-8. PMID 8674660 DOI: 10.1042/bst0240193 |
0.54 |
|
| 1996 |
Krause M, Rouleau A, Stark H, Luger P, Garbarg M, Schwartz JC, Schunack W. New potent azomethine prodrugs of the histamine H3-receptor agonist (R)-alpha-methylhistamine containing a heteroarylphenyl partial structure. Archiv Der Pharmazie. 329: 209-15. PMID 8669985 DOI: 10.1002/Ardp.19963290407 |
0.449 |
|
| 1996 |
Stark H, Purand K, Hüls A, Ligneau X, Garbarg M, Schwartz JC, Schunack W. [125I]iodoproxyfan and related compounds: a reversible radioligand and novel classes of antagonists with high affinity and selectivity for the histamine H3 receptor. Journal of Medicinal Chemistry. 39: 1220-6. PMID 8632428 DOI: 10.1021/Jm9504767 |
0.476 |
|
| 1995 |
Schwartz JC, Griffon N, Diaz J, Levesque D, Sautel F, Sokoloff P, Simon P, Costentin J, Garrido F, Mann A. The D3 receptor and its relevance in psychiatry. International Clinical Psychopharmacology. 10: 15-20. PMID 8866761 |
0.335 |
|
| 1995 |
Griffon N, Sokoloff P, Diaz J, Lévesque D, Sautel F, Schwartz JC, Simon P, Costentin J, Garrido F, Mann A. The dopamine D3 receptor and schizophrenia: pharmacological, anatomical and genetic approaches. European Neuropsychopharmacology : the Journal of the European College of Neuropsychopharmacology. 5: 3-9. PMID 8775753 DOI: 10.1016/0924-977X(95)00030-S |
0.595 |
|
| 1995 |
Normant E, Martres MP, Schwartz JC, Gros C. Purification, cDNA cloning, functional expression, and characterization of a 26-kDa endogenous mammalian carboxypeptidase inhibitor. Proceedings of the National Academy of Sciences of the United States of America. 92: 12225-9. PMID 8618874 DOI: 10.1073/Pnas.92.26.12225 |
0.329 |
|
| 1995 |
Sautel F, Griffon N, Sokoloff P, Schwartz JC, Launay C, Simon P, Costentin J, Schoenfelder A, Garrido F, Mann A. Nafadotride, a potent preferential dopamine D3 receptor antagonist, activates locomotion in rodents. The Journal of Pharmacology and Experimental Therapeutics. 275: 1239-46. PMID 8531087 |
0.365 |
|
| 1995 |
Lévesque D, Martres MP, Diaz J, Griffon N, Lammers CH, Sokoloff P, Schwartz JC. A paradoxical regulation of the dopamine D3 receptor expression suggests the involvement of an anterograde factor from dopamine neurons. Proceedings of the National Academy of Sciences of the United States of America. 92: 1719-23. PMID 7878047 DOI: 10.1073/Pnas.92.5.1719 |
0.475 |
|
| 1995 |
Traiffort E, Vizuete ML, Tardivel-Lacombe J, Souil E, Schwartz JC, Ruat M. The guinea pig histamine H2 receptor: gene cloning, tissue expression and chromosomal localization of its human counterpart. Biochemical and Biophysical Research Communications. 211: 570-7. PMID 7794271 DOI: 10.1006/Bbrc.1995.1851 |
0.69 |
|
| 1995 |
Sautel F, Griffon N, Lévesque D, Pilon C, Schwartz JC, Sokoloff P. A functional test identifies dopamine agonists selective for D3 versus D2 receptors. Neuroreport. 6: 329-32. PMID 7756621 DOI: 10.1097/00001756-199501000-00026 |
0.441 |
|
| 1995 |
Ganellin CR, Fkyerat A, Hosseini SK, Khalaf YS, Piripitsi A, Tertiuk W, Arrang JM, Garbarg M, Ligneau X, Schwartz JC. Structure-activity studies with histamine H3-receptor ligands. Journal De Pharmacie De Belgique. 50: 179-87. PMID 7674117 |
0.371 |
|
| 1995 |
Normant E, Gros C, Schwartz JC. Carboxypeptidase A isoforms produced by distinct genes or alternative splicing in brain and other extrapancreatic tissues. The Journal of Biological Chemistry. 270: 20543-9. PMID 7657630 DOI: 10.1074/Jbc.270.35.20543 |
0.314 |
|
| 1995 |
Vizuete ML, Dimitriadou V, Traiffort E, Griffon N, Heron A, Schwartz JC. Endogenous histamine induces c-fos expression within paraventricular and supraoptic nuclei. Neuroreport. 6: 1041-4. PMID 7632891 DOI: 10.1097/00001756-199505090-00023 |
0.698 |
|
| 1995 |
Kieć-Kononowicz K, Ligneau X, Schwartz JC, Schunack W. Pyrazoles as potential histamine H3-receptor antagonists. Archiv Der Pharmazie. 328: 469-72. PMID 7611843 DOI: 10.1002/Ardp.19953280513 |
0.506 |
|
| 1995 |
Kieć-Kononowicz K, Ligneau X, Stark H, Schwartz JC, Schunack W. Azines and diazines as potential histamine H3-receptor antagonists. Archiv Der Pharmazie. 328: 445-50. PMID 7611840 DOI: 10.1002/Ardp.19953280509 |
0.505 |
|
| 1995 |
Arrang JM, Drutel G, Garbarg M, Ruat M, Traiffort E, Schwartz JC. Molecular and functional diversity of histamine receptor subtypes. Annals of the New York Academy of Sciences. 757: 314-23. PMID 7611688 DOI: 10.1111/J.1749-6632.1995.Tb17489.X |
0.671 |
|
| 1995 |
Sokoloff P, Diaz J, Levesque D, Pilon C, Dimitriadou V, Griffon N, Lammers CH, Martres MP, Schwartz JC. Novel dopamine receptor subtypes as targets for antipsychotic drugs. Annals of the New York Academy of Sciences. 757: 278-92. PMID 7611685 DOI: 10.1111/J.1749-6632.1995.Tb17486.X |
0.388 |
|
| 1995 |
Diaz J, Lévesque D, Lammers CH, Griffon N, Martres MP, Schwartz JC, Sokoloff P. Phenotypical characterization of neurons expressing the dopamine D3 receptor in the rat brain. Neuroscience. 65: 731-45. PMID 7609872 |
0.351 |
|
| 1995 |
Arrang JM, Drutel G, Schwartz JC. Characterization of histamine H3 receptors regulating acetylcholine release in rat entorhinal cortex. British Journal of Pharmacology. 114: 1518-22. PMID 7606356 |
0.392 |
|
| 1995 |
Göthert M, Garbarg M, Hey JA, Schlicker E, Schwartz JC, Levi R. New aspects of the role of histamine in cardiovascular function: identification, characterization, and potential pathophysiological importance of H3 receptors. Canadian Journal of Physiology and Pharmacology. 73: 558-64. PMID 7585321 DOI: 10.1139/y95-071 |
0.368 |
|
| 1995 |
Griffon N, Pilon C, Schwartz JC, Sokoloff P. The preferential dopamine D3 receptor ligand, (+)-UH232, is a partial agonist. European Journal of Pharmacology. 282: R3-4. PMID 7498261 DOI: 10.1016/0014-2999(95)00460-3 |
0.483 |
|
| 1995 |
Sokoloff P, Schwartz JC. Novel dopamine receptors half a decade later. Trends in Pharmacological Sciences. 16: 270-5. PMID 7482988 DOI: 10.1016/S0165-6147(00)89044-6 |
0.469 |
|
| 1995 |
Mei YA, Griffon N, Buquet C, Martres MP, Vaudry H, Schwartz JC, Sokoloff P, Cazin L. Activation of dopamine D4 receptor inhibits an L-type calcium current in cerebellar granule cells. Neuroscience. 68: 107-16. PMID 7477916 |
0.302 |
|
| 1995 |
Schwartz JC, Griffon N, Diaz J, Levesque D, Sautel F, Sokoloff P, Simon P, Costentin J, Garrido F, Mann A, Wermuth C. The D3 receptor and its relevance in psychiatry International Clinical Psychopharmacology. 10: 15-20. DOI: 10.1097/00004850-199509000-00003 |
0.545 |
|
| 1995 |
Schwartz J, Sokoloff P. Schwartz and Sokoloff reply: Selective agonists and antagonists are needed to determine a functional role for dopamine D3 receptors Trends in Pharmacological Sciences. 16: 407-408. DOI: 10.1016/S0165-6147(00)89089-6 |
0.445 |
|
| 1995 |
Stark H, Lipp R, Arrang JM, Garbarg M, Ligneau X, Schwartz JC, Schunack W. New potent histamine H3-receptor antagonists of the amide type European Journal of Pharmaceutical Sciences. 3: 95-104. DOI: 10.1016/0928-0987(94)00079-F |
0.466 |
|
| 1995 |
Lipp R, Stark H, Arrang JM, Garbarg M, Schwartz JC, Schunack W. Synthesis and histamine H3-receptor agonist activity of mono- and dialkyl-substituted histamine derivatives European Journal of Medicinal Chemistry. 30: 219-225. DOI: 10.1016/0223-5234(96)88228-6 |
0.456 |
|
| 1994 |
Leurs R, Traiffort E, Arrang JM, Tardivel-Lacombe J, Ruat M, Schwartz JC. Guinea pig histamine H1 receptor. II. Stable expression in Chinese hamster ovary cells reveals the interaction with three major signal transduction pathways. Journal of Neurochemistry. 62: 519-27. PMID 8294914 DOI: 10.1046/J.1471-4159.1994.62020519.X |
0.632 |
|
| 1994 |
Traiffort E, Leurs R, Arrang JM, Tardivel-Lacombe J, Diaz J, Schwartz JC, Ruat M. Guinea pig histamine H1 receptor. I. Gene cloning, characterization, and tissue expression revealed by in situ hybridization. Journal of Neurochemistry. 62: 507-18. PMID 8294913 DOI: 10.1046/J.1471-4159.1994.62020507.X |
0.692 |
|
| 1994 |
Griffon N, Mignon V, Facchinetti P, Diaz J, Schwartz JC, Sokoloff P. Molecular cloning and characterization of the rat fifth melanocortin receptor. Biochemical and Biophysical Research Communications. 200: 1007-14. PMID 8179577 |
0.314 |
|
| 1994 |
Diaz J, Vizuete ML, Traiffort E, Arrang JM, Ruat M, Schwartz JC. Localization of the histamine H2 receptor and gene transcripts in rat stomach: back to parietal cells. Biochemical and Biophysical Research Communications. 198: 1195-202. PMID 8117277 DOI: 10.1006/Bbrc.1994.1169 |
0.684 |
|
| 1994 |
Schwartz JC, Diaz J, Griffon N, Levesque D, Martres MP, Sokoloff P. Multiple dopamine receptors: the D3 receptor and actions of substances of abuse. Exs. 71: 81-92. PMID 8032175 |
0.353 |
|
| 1994 |
Diaz J, Lévesque D, Griffon N, Lammers CH, Martres MP, Sokoloff P, Schwartz JC. Opposing roles for dopamine D2 and D3 receptors on neurotensin mRNA expression in nucleus accumbens. The European Journal of Neuroscience. 6: 1384-7. PMID 7981879 |
0.312 |
|
| 1994 |
Ligneau X, Garbarg M, Vizuete ML, Diaz J, Purand K, Stark H, Schunack W, Schwartz JC. [125I]iodoproxyfan, a new antagonist to label and visualize cerebral histamine H3 receptors. The Journal of Pharmacology and Experimental Therapeutics. 271: 452-9. PMID 7965746 |
0.397 |
|
| 1994 |
Pilon C, Lévesque D, Dimitriadou V, Griffon N, Martres MP, Schwartz JC, Sokoloff P. Functional coupling of the human dopamine D3 receptor in a transfected NG 108-15 neuroblastoma-glioma hybrid cell line. European Journal of Pharmacology. 268: 129-39. PMID 7957635 DOI: 10.1016/0922-4106(94)90182-1 |
0.492 |
|
| 1993 |
Rietschel M, Nöthen MM, Lannfelt L, Sokoloff P, Schwartz JC, Lanczik M, Fritze J, Cichon S, Fimmers R, Körner J. A serine to glycine substitution at position 9 in the extracellular N-terminal part of the dopamine D3 receptor protein: no role in the genetic predisposition to bipolar affective disorder. Psychiatry Research. 46: 253-9. PMID 8493294 DOI: 10.1016/0165-1781(93)90093-V |
0.357 |
|
| 1993 |
Wiese C, Lannfelt L, Kristbjarnarson H, Yang L, Zoega T, Sokoloff P, Ivarsson O, Schwartz JC, Moises HW, Helgason T. No evidence of linkage between schizophrenia and D3 dopamine receptor gene locus in Icelandic pedigrees. Psychiatry Research. 46: 69-78. PMID 8464957 DOI: 10.1016/0165-1781(93)90009-6 |
0.353 |
|
| 1993 |
Ruat M, Traiffort E, Leurs R, Tardivel-Lacombe J, Diaz J, Arrang JM, Schwartz JC. Molecular cloning, characterization, and localization of a high-affinity serotonin receptor (5-HT7) activating cAMP formation. Proceedings of the National Academy of Sciences of the United States of America. 90: 8547-51. PMID 8397408 DOI: 10.1073/Pnas.90.18.8547 |
0.611 |
|
| 1993 |
Søe-Jensen P, Knigge U, Garbarg M, Kjaer A, Rouleau A, Bach FW, Schwartz JC, Warberg J. Responses of anterior pituitary hormones and hypothalamic histamine to blockade of histamine synthesis and to selective activation or inactivation of presynaptic histamine H3 receptors in stressed rats. Neuroendocrinology. 57: 532-40. PMID 8391665 DOI: 10.1159/000126402 |
0.407 |
|
| 1993 |
Ruat M, Traiffort E, Arrang JM, Tardivel-Lacombe J, Diaz J, Leurs R, Schwartz JC. A novel rat serotonin (5-HT6) receptor: molecular cloning, localization and stimulation of cAMP accumulation. Biochemical and Biophysical Research Communications. 193: 268-76. PMID 8389146 DOI: 10.1006/Bbrc.1993.1619 |
0.655 |
|
| 1993 |
Pollard H, Moreau J, Arrang JM, Schwartz JC. A detailed autoradiographic mapping of histamine H3 receptors in rat brain areas. Neuroscience. 52: 169-89. PMID 8381924 |
0.369 |
|
| 1993 |
Garbarg M, Schwartz JC. The histamine H3 receptor: pharmacology and potential therapeutic applications. Annales Franã§Aises D'Anesthã¨Sie Et De Rã¨Animation. 12: 114-5. PMID 8368582 DOI: 10.1016/S0750-7658(05)81019-6 |
0.34 |
|
| 1993 |
Schwartz JC, Levesque D, Martres MP, Sokoloff P. Dopamine D3 receptor: basic and clinical aspects. Clinical Neuropharmacology. 16: 295-314. PMID 8104095 DOI: 10.1097/00002826-199308000-00002 |
0.457 |
|
| 1993 |
Yang L, Li T, Wiese C, Lannfelt L, Sokoloff P, Xu CT, Zeng Z, Schwartz JC, Liu X, Moises HW. No association between schizophrenia and homozygosity at the D3 dopamine receptor gene. American Journal of Medical Genetics. 48: 83-6. PMID 8103292 DOI: 10.1002/Ajmg.1320480205 |
0.38 |
|
| 1993 |
Giros B, Sokoloff P, Martres MP, Lannfelt L, Andrieux M, Besançon R, Pilon C, Bouthenet ML, Souil E, Schwartz JC. The third dopamine receptor (D3): new perspectives in therapeutics. Psychopharmacology Series. 10: 82-93. PMID 8103228 DOI: 10.1007/978-3-642-78010-3_8 |
0.595 |
|
| 1993 |
MartÃnez-Mir MI, Pollard H, Moreau J, Traiffort E, Ruat M, Schwartz JC, Palacios JM. Loss of striatal histamine H2 receptors in Huntington's chorea but not in Parkinson's disease: comparison with animal models. Synapse (New York, N.Y.). 15: 209-20. PMID 7904088 DOI: 10.1002/Syn.890150306 |
0.657 |
|
| 1993 |
Di Marzo V, Vial D, Sokoloff P, Schwartz JC, Piomelli D. Selection of alternative G-mediated signaling pathways at the dopamine D2 receptor by protein kinase C. The Journal of Neuroscience : the Official Journal of the Society For Neuroscience. 13: 4846-53. PMID 7693893 DOI: 10.1523/Jneurosci.13-11-04846.1993 |
0.423 |
|
| 1992 |
Ruat M, Traiffort E, Garbarg M, Schwartz JC, Demonchaux P, Ife RJ, Tertiuk W, Ganellin CR. Design of an affinity matrix for purification of the histamine H1 receptor from guinea pig cerebellum. Journal of Neurochemistry. 58: 350-6. PMID 1727441 DOI: 10.1111/J.1471-4159.1992.Tb09317.X |
0.655 |
|
| 1992 |
Hirschfeld J, Buschauer A, Elz S, Schunack W, Ruat M, Traiffort E, Schwartz JC. Iodoaminopotentidine and related compounds: a new class of ligands with high affinity and selectivity for the histamine H2 receptor. Journal of Medicinal Chemistry. 35: 2231-8. PMID 1613748 DOI: 10.1021/Jm00090A013 |
0.662 |
|
| 1992 |
Sokoloff P, Giros B, Martres MP, Andrieux M, Besancon R, Pilon C, Bouthenet ML, Souil E, Schwartz JC. Localization and function of the D3 dopamine receptor. Arzneimittel-Forschung. 42: 224-30. PMID 1586393 |
0.604 |
|
| 1992 |
Lévesque D, Diaz J, Pilon C, Martres MP, Giros B, Souil E, Schott D, Morgat JL, Schwartz JC, Sokoloff P. Identification, characterization, and localization of the dopamine D3 receptor in rat brain using 7-[3H]hydroxy-N,N-di-n-propyl-2-aminotetralin. Proceedings of the National Academy of Sciences of the United States of America. 89: 8155-9. PMID 1518841 DOI: 10.1073/Pnas.89.17.8155 |
0.628 |
|
| 1992 |
Ruat M, Traiffort E, Leurs R, Arrang JM, Kouyoumdjian G, Tardivel-Lacombe J, Piomelli D, Diaz G, Schwartz JC. Molecular biology and pharmacology of histamine receptor subtypes. Clinical Neuropharmacology. 15: 149A-150A. PMID 1498787 |
0.654 |
|
| 1992 |
Schwartz JC. Multiple dopamine receptors: functional implications. Clinical Neuropharmacology. 15: 1A-2A. PMID 1498771 |
0.302 |
|
| 1992 |
Garbarg M, Arrang JM, Rouleau A, Ligneau X, Tuong MD, Schwartz JC, Ganellin CR. S-[2-(4-imidazolyl)ethyl]isothiourea, a highly specific and potent histamine H3 receptor agonist. The Journal of Pharmacology and Experimental Therapeutics. 263: 304-10. PMID 1383495 |
0.344 |
|
| 1992 |
Sokoloff P, Martres MP, Giros B, Bouthenet ML, Schwartz JC. Heterogeneity and regulation of central dopamine receptor subtypes studied by cDNA cloning methodology. Neurochemistry International. 20: 27S-32S. PMID 1365440 DOI: 10.1016/0197-0186(92)90207-8 |
0.625 |
|
| 1992 |
Martres MP, Sokoloff P, Giros B, Bouthenet ML, Pilon C, Lannfelt L, Schwartz JC. [Dopaminergic receptors, multiple targets for neuroleptics]. Annales Mã©Dico-Psychologiques. 150: 119-23. PMID 1364189 |
0.558 |
|
| 1992 |
Sokoloff P, Andrieux M, Besançon R, Pilon C, Martres MP, Giros B, Schwartz JC. Pharmacology of human dopamine D3 receptor expressed in a mammalian cell line: comparison with D2 receptor. European Journal of Pharmacology. 225: 331-7. PMID 1354163 DOI: 10.1016/0922-4106(92)90107-7 |
0.635 |
|
| 1992 |
Traiffort E, Pollard H, Moreau J, Ruat M, Schwartz JC, Martinez-Mir MI, Palacios JM. Pharmacological characterization and autoradiographic localization of histamine H2 receptors in human brain identified with [125I]iodoaminopotentidine. Journal of Neurochemistry. 59: 290-9. PMID 1351926 DOI: 10.1111/J.1471-4159.1992.Tb08903.X |
0.701 |
|
| 1992 |
Sokoloff P, Martres MP, Giros B, Bouthenet ML, Schwartz JC. The third dopamine receptor (D3) as a novel target for antipsychotics. Biochemical Pharmacology. 43: 659-66. PMID 1347215 DOI: 10.1016/0006-2952(92)90227-A |
0.612 |
|
| 1992 |
Traiffort E, Ruat M, Arrang JM, Leurs R, Piomelli D, Schwartz JC. Expression of a cloned rat histamine H2 receptor mediating inhibition of arachidonate release and activation of cAMP accumulation. Proceedings of the National Academy of Sciences of the United States of America. 89: 2649-53. PMID 1313563 DOI: 10.1073/Pnas.89.7.2649 |
0.729 |
|
| 1992 |
Martres MP, Sokoloff P, Giros B, Schwartz JC. Effects of dopaminergic transmission interruption on the D2 receptor isoforms in various cerebral tissues. Journal of Neurochemistry. 58: 673-9. PMID 1309568 DOI: 10.1111/J.1471-4159.1992.Tb09770.X |
0.584 |
|
| 1992 |
Schwartz JC, Giros B, Martres MP, Sokoloff P. The dopamine receptor family: molecular biology and pharmacology Seminars in Neuroscience. 4: 99-108. DOI: 10.1016/1044-5765(92)90008-P |
0.631 |
|
| 1991 |
Giros B, Martres MP, Pilon C, Sokoloff P, Schwartz JC. Shorter variants of the D3 dopamine receptor produced through various patterns of alternative splicing. Biochemical and Biophysical Research Communications. 176: 1584-92. PMID 2039532 DOI: 10.1016/0006-291X(91)90469-N |
0.624 |
|
| 1991 |
Ruat M, Traiffort E, Arrang JM, Leurs R, Schwartz JC. Cloning and tissue expression of a rat histamine H2-receptor gene. Biochemical and Biophysical Research Communications. 179: 1470-8. PMID 1930188 DOI: 10.1016/0006-291X(91)91738-X |
0.697 |
|
| 1991 |
Le Coniat M, Sokoloff P, Hillion J, Martres MP, Giros B, Pilon C, Schwartz JC, Berger R. Chromosomal localization of the human D3 dopamine receptor gene. Human Genetics. 87: 618-20. PMID 1916765 DOI: 10.1007/Bf00209024 |
0.585 |
|
| 1991 |
Piomelli D, Pilon C, Giros B, Sokoloff P, Martres MP, Schwartz JC. Dopamine activation of the arachidonic acid cascade as a basis for D1/D2 receptor synergism. Nature. 353: 164-7. PMID 1909771 DOI: 10.1038/353164a0 |
0.589 |
|
| 1991 |
Traiffort E, Ruat M, Schwartz JC. Interaction of mianserin, amitriptyline and haloperidol with guinea pig cerebral histamine H2 receptors studied with [125I]iodoaminopotentidine. European Journal of Pharmacology. 207: 143-8. PMID 1879459 DOI: 10.1016/0922-4106(91)90089-Z |
0.708 |
|
| 1991 |
Bouthenet ML, Souil E, Martres MP, Sokoloff P, Giros B, Schwartz JC. Localization of dopamine D3 receptor mRNA in the rat brain using in situ hybridization histochemistry: comparison with dopamine D2 receptor mRNA. Brain Research. 564: 203-19. PMID 1839781 DOI: 10.1016/0006-8993(91)91456-B |
0.587 |
|
| 1991 |
Lipp R, Arrang JM, Buschmann J, Garbarg M, Luger P, Schunack W, Schwartz JC. Novel chiral H3-receptor agonists. Agents and Actions. Supplements. 33: 277-82. PMID 1711275 DOI: 10.1007/978-3-0348-7309-3_18 |
0.377 |
|
| 1991 |
Ruat M, Traiffort E, Bouthenet ML, Souil E, Pollard H, Moreau J, Schwartz JC, Martinez-Mir I, Palacios JM, Hirschfeld J. Reversible and irreversible labelling of H1- and H2 -receptors using novel [125I] probes. Agents and Actions. Supplements. 33: 123-44. PMID 1675831 |
0.697 |
|
| 1991 |
Llorens-Cortes C, Zini S, Gros C, Schwartz JC. Dopaminergic regulation of enkephalin release. Journal of Neurochemistry. 56: 1368-75. PMID 1672147 DOI: 10.1111/j.1471-4159.1991.tb11434.x |
0.376 |
|
| 1991 |
Ganellin CR, Jayes D, Khalaf YS, Tertiuk W, Arrang J, Defontaine N, Schwartz J. Synthesis of pyridyl isosteres of thioperamide as H3-receptor histamine antagonists Collection of Czechoslovak Chemical Communications. 56: 2448-2455. DOI: 10.1135/Cccc19912448 |
0.456 |
|
| 1990 |
Schwartz JC, Arrang JM, Garbarg M, Pollard H. Histamine H3 receptors in the brain: potent and selective ligands. Psychopharmacology Series. 7: 10-9. PMID 2687850 DOI: 10.1007/978-3-642-74430-3_2 |
0.346 |
|
| 1990 |
Ruat M, Traiffort E, Bouthenet ML, Schwartz JC, Hirschfeld J, Buschauer A, Schunack W. Reversible and irreversible labeling and autoradiographic localization of the cerebral histamine H2 receptor using [125I]iodinated probes. Proceedings of the National Academy of Sciences of the United States of America. 87: 1658-62. PMID 2308927 DOI: 10.1073/Pnas.87.5.1658 |
0.704 |
|
| 1990 |
Llorens-Cortes C, Giros B, Schwartz JC. A novel potential metallopeptidase derived from the enkephalinase gene by alternative splicing. Journal of Neurochemistry. 55: 2146-8. PMID 2230815 DOI: 10.1111/J.1471-4159.1990.Tb05810.X |
0.522 |
|
| 1990 |
Llorens-Cortes C, Van Amsterdam JG, Giros B, Quach TT, Schwartz JC. Enkephalin biosynthesis and release in mouse striatum are inhibited by GABA receptor stimulation: compared changes in preproenkephalin mRNA and Tyr-Gly-Gly levels. Brain Research. Molecular Brain Research. 8: 227-33. PMID 2170800 DOI: 10.1016/0169-328X(90)90021-5 |
0.589 |
|
| 1990 |
Lin JS, Sakai K, Vanni-Mercier G, Arrang JM, Garbarg M, Schwartz JC, Jouvet M. Involvement of histaminergic neurons in arousal mechanisms demonstrated with H3-receptor ligands in the cat. Brain Research. 523: 325-30. PMID 2169324 DOI: 10.1016/0006-8993(90)91508-E |
0.424 |
|
| 1990 |
Lecomte J, Baumer P, Lim C, Duchier J, Cournot A, Dussaule J, Ardaillou R, Gros C, Chaignon B, Souque A, Schwartz J. Stereoselective protection of exogenous and endogenous atrial natriuretic factor by enkephalinase inhibitors in mice and humans. European Journal of Pharmacology. 179: 65-73. PMID 2163851 DOI: 10.1016/0014-2999(90)90402-R |
0.315 |
|
| 1990 |
Llorens-Cortes C, Giros B, Quach TT, Schwartz JC. Adaptative changes in two indices of enkephalin neuron activity in mouse striatum following GABAergic stimulation. Progress in Clinical and Biological Research. 328: 203-6. PMID 2154779 |
0.462 |
|
| 1990 |
Giros B, Martres MP, Sokoloff P, Schwartz JC. [Gene cloning of human dopaminergic D3 receptor and identification of its chromosome]. Comptes Rendus De L'Acadã©Mie Des Sciences. Sã©Rie Iii, Sciences De La Vie. 311: 501-8. PMID 2129115 |
0.544 |
|
| 1990 |
Michael-Titus A, Dourmap N, Costentin J, Schwartz JC. Role of delta opioid receptors in the effects of inhibitors of enkephalin-degrading peptidases on the horizontal and vertical components of locomotion in mice. Neuropeptides. 15: 89-100. PMID 1981928 DOI: 10.1016/0143-4179(90)90044-Y |
0.479 |
|
| 1990 |
Martinez-Mir MI, Pollard H, Moreau J, Arrang JM, Ruat M, Traiffort E, Schwartz JC, Palacios JM. Three histamine receptors (H1, H2 and H3) visualized in the brain of human and non-human primates. Brain Research. 526: 322-7. PMID 1979518 DOI: 10.1016/0006-8993(90)91240-H |
0.683 |
|
| 1990 |
Rognan D, Sokoloff P, Mann A, Martres MP, Schwartz JC, Costentin J, Wermuth CG. Optically active benzamides as predictive tools for mapping the dopamine D2 receptor. European Journal of Pharmacology. 189: 59-70. PMID 1977603 DOI: 10.1016/0922-4106(90)90230-U |
0.57 |
|
| 1990 |
Sokoloff P, Giros B, Martres MP, Bouthenet ML, Schwartz JC. Molecular cloning and characterization of a novel dopamine receptor (D3) as a target for neuroleptics. Nature. 347: 146-51. PMID 1975644 DOI: 10.1038/347146A0 |
0.596 |
|
| 1990 |
Arrang JM, Roy J, Morgat JL, Schunack W, Schwartz JC. Histamine H3 receptor binding sites in rat brain membranes: modulations by guanine nucleotides and divalent cations. European Journal of Pharmacology. 188: 219-27. PMID 1694777 DOI: 10.1016/0922-4106(90)90005-I |
0.472 |
|
| 1990 |
Gulat-Marnay C, Lafitte A, Arrang JM, Schwartz JC. Modulation of histamine release in the rat brain by kappa-opioid receptors. Journal of Neurochemistry. 55: 47-53. PMID 1693948 DOI: 10.1111/J.1471-4159.1990.Tb08819.X |
0.445 |
|
| 1989 |
Vargas F, Tuong MD, Schwartz JC. Inhibitors and dipeptide substrates for a microsomal tyrosylsulfotransferase from rat brain. Journal of Enzyme Inhibition. 1: 105-12. PMID 3508909 DOI: 10.3109/14756368609020109 |
0.319 |
|
| 1989 |
Arrang JM, Defontaine N, Schwartz JC. Phencyclidine blocks histamine H3-receptors in rat brain. European Journal of Pharmacology. 157: 31-5. PMID 2853072 DOI: 10.1016/0014-2999(88)90467-0 |
0.495 |
|
| 1989 |
Arrang JM, Garbarg M, Lancelot JC, Lecomte JM, Pollard H, Robba M, Schunack W, Schwartz JC. Highly potent and selective ligands for a new class H3 of histamine receptor. Investigative Radiology. S130-2. PMID 2848779 DOI: 10.1097/00004424-198809001-00017 |
0.365 |
|
| 1989 |
Ruat M, Schwartz JC. Photoaffinity labeling and electrophoretic identification of the H1-receptor: comparison of several brain regions and animal species. Journal of Neurochemistry. 53: 335-9. PMID 2746224 DOI: 10.1111/J.1471-4159.1989.Tb07339.X |
0.424 |
|
| 1989 |
Llorens-Cortes C, Martres MP, Van Amsterdam Y, Giros B, Gros C, Pollard H, Schwartz JC. [Dopamine and enkephalins. Effects of dopaminergic agents on the levels of striatal tyrosyl-glycyl-glycine]. L'Encã©Phale. 15: 105-9. PMID 2743934 |
0.483 |
|
| 1989 |
Garbarg M, Tuong MD, Gros C, Schwartz JC. Effects of histamine H3-receptor ligands on various biochemical indices of histaminergic neuron activity in rat brain. European Journal of Pharmacology. 164: 1-11. PMID 2568933 DOI: 10.1016/0014-2999(89)90225-2 |
0.34 |
|
| 1989 |
Malfroy B, Kado-Fong H, Gros C, Giros B, Schwartz JC, Hellmiss R. Molecular cloning and amino acid sequence of rat kidney aminopeptidase M: a member of a super family of zinc-metallohydrolases. Biochemical and Biophysical Research Communications. 161: 236-41. PMID 2567164 DOI: 10.1016/0006-291X(89)91586-6 |
0.519 |
|
| 1989 |
Gulat-Marnay C, Lafitte A, Arrang J, Schwartz J. Modulation of Histamine Release and Synthesis in the Brain Mediated by α2‐Adrenoceptors Journal of Neurochemistry. 53: 519-524. PMID 2545819 DOI: 10.1111/J.1471-4159.1989.Tb07364.X |
0.42 |
|
| 1989 |
Giros B, Sokoloff P, Martres MP, Riou JF, Emorine LJ, Schwartz JC. Alternative splicing directs the expression of two D2 dopamine receptor isoforms. Nature. 342: 923-6. PMID 2531847 DOI: 10.1038/342923A0 |
0.64 |
|
| 1989 |
Sokoloff P, Riou JF, Martres MP, Schwartz JC. Presence of dopamine D-2 receptors in human tumoral cell lines. Biochemical and Biophysical Research Communications. 162: 575-82. PMID 2527031 DOI: 10.1016/0006-291X(89)92349-8 |
0.375 |
|
| 1989 |
Gulat-Marnay C, Lafitte A, Arrang JM, Schwartz JC. Regulation of histamine release and synthesis in the brain by muscarinic receptors. Journal of Neurochemistry. 52: 248-54. PMID 2462019 DOI: 10.1111/J.1471-4159.1989.Tb10924.X |
0.467 |
|
| 1988 |
Ruat M, Körner M, Garbarg M, Gros C, Schwartz JC, Tertiuk W, Ganellin CR. Characterization of histamine H1-receptor binding peptides in guinea pig brain using [125I]iodoazidophenpyramine, an irreversible specific photoaffinity probe. Proceedings of the National Academy of Sciences of the United States of America. 85: 2743-7. PMID 3357888 |
0.372 |
|
| 1988 |
Gros C, Giros B, Schwartz JC, Vlaiculescu A, Costentin J, Lecomte JM. Potent inhibition of cerebral aminopeptidases by carbaphethiol, a parenterally active compound. Neuropeptides. 12: 111-8. PMID 3241626 DOI: 10.1016/0143-4179(88)90040-6 |
0.504 |
|
| 1988 |
Bouthenet ML, Ruat M, Sales N, Garbarg M, Schwartz JC. A detailed mapping of histamine H1-receptors in guinea-pig central nervous system established by autoradiography with [125I]iodobolpyramine. Neuroscience. 26: 553-600. PMID 3173689 DOI: 10.1016/0306-4522(88)90167-4 |
0.329 |
|
| 1988 |
De la Baume S, Schwartz JC. Labelling and exploration of the active site of enkephalinase (EC 3.4.24.11) in kidney membranes with [3H]thiorphan as ligand. European Journal of Pharmacology. 149: 121-9. PMID 3165067 DOI: 10.1016/0014-2999(88)90049-0 |
0.361 |
|
| 1988 |
Arrang JM, Devaux B, Chodkiewicz JP, Schwartz JC. H3-receptors control histamine release in human brain. Journal of Neurochemistry. 51: 105-8. PMID 2454293 DOI: 10.1111/J.1471-4159.1988.Tb04841.X |
0.428 |
|
| 1988 |
Arrang JM, Garbarg M, Schwartz JC. Autoinhibition of histamine synthesis mediated by presynaptic H3-receptors. Neuroscience. 23: 149-57. PMID 2446202 DOI: 10.1016/0306-4522(87)90279-X |
0.377 |
|
| 1988 |
ARRANG JM, GARBARG M, LANCELOT JC, LECOMTE JM, POLLARD H, ROBBA M, SCHUNACK W, SCHWARTZ JC. Highly Potent and Selective Ligands for a New Class H3 of Histamine Receptor Investigative Radiology. 23: S133. DOI: 10.1097/00004424-198809000-00019 |
0.31 |
|
| 1987 |
Pollard H, De la Baume S, Bouthenet ML, Schwartz JC, Ronco P, Verroust P. Characterisation of two probes for the localisation of enkephalinase in rat brain: [3H]thiorphan and a 125I-labeled monoclonal antibody. European Journal of Pharmacology. 133: 155-64. PMID 3545855 DOI: 10.1016/0014-2999(87)90146-4 |
0.335 |
|
| 1987 |
Brion F, Schwartz JC, Vargas F. Properties and localization of the sulfate-activating system in rat brain. Journal of Neurochemistry. 48: 1171-7. PMID 3493327 DOI: 10.1111/J.1471-4159.1987.Tb05643.X |
0.307 |
|
| 1987 |
Marçais-Collado H, Uchida G, Costentin J, Schwartz JC, Lecomte JM. Naloxone-reversible antidiarrheal effects of enkephalinase inhibitors. European Journal of Pharmacology. 144: 125-32. PMID 3481337 DOI: 10.1016/0014-2999(87)90510-3 |
0.51 |
|
| 1987 |
Giros B, Gros C, Schwartz JC, Danvy D, Plaquevent JC, Duhamel L, Duhamel P, Vlaiculescu A, Costentin J, Lecomte JM. Enantiomers of thiorphan and acetorphan: correlation between enkephalinase inhibition, protection of endogenous enkephalins and behavioral effects. The Journal of Pharmacology and Experimental Therapeutics. 243: 666-73. PMID 3479550 |
0.505 |
|
| 1987 |
Garbarg M, Schwartz JC. Histamine receptors in the brain. New England and Regional Allergy Proceedings. 6: 195-200. PMID 3041196 DOI: 10.2500/108854185779045233 |
0.501 |
|
| 1987 |
Giros B, Gros C, Llorens-Cortes C, Schwartz JC. [Opioid peptides: metabolism and receptors]. Gastroentã©Rologie Clinique Et Biologique. 11: 7B-13B. PMID 3038654 |
0.507 |
|
| 1987 |
Giros B, Schwartz JC. [Opioid peptides and their receptors]. La Revue Du Praticien. 37: 1695-8, 1701-2. PMID 3035700 |
0.513 |
|
| 1987 |
Schwartz JC, Giros B, Gros C, Llorens-Cortes C, Arrang JM, Garbarg M, Pollard H. Novel agents affecting enkephalinergic and histaminergic transmissions in brain. Cephalalgia : An International Journal of Headache. 7: 32-5. PMID 2894899 DOI: 10.1177/03331024870070S610 |
0.452 |
|
| 1987 |
Pollard H, Llorens-Cortes C, Couraud J, Ronco P, Verroust P, Schwartz J. Enkephalinase (EC 3.4.24.11) is highly localized to a striatonigral pathway in rat brain. Neuroscience Letters. 77: 267-271. PMID 2441326 DOI: 10.1016/0304-3940(87)90510-6 |
0.311 |
|
| 1987 |
Blakemore RC, Ganellin CR, Garbarg M, Gros C, Ife RJ, Körner M, Ruat M, Schwartz JC, Tertiuk W, Theobald CJ. Iodobolpyramine and other iodinated derivatives as ligands for detecting histamine H1 receptors European Journal of Medicinal Chemistry. 22: 91-100. DOI: 10.1016/0223-5234(87)90002-X |
0.466 |
|
| 1986 |
Korner M, Bouthenet ML, Ganellin CR, Garbarg M, Gros C, Ife RJ, Sales N, Schwartz JC. [125I]Iodobolpyramine, a highly sensitive probe for histamine H1-receptors in guinea-pig brain. European Journal of Pharmacology. 120: 151-60. PMID 3948916 DOI: 10.1016/0014-2999(86)90535-2 |
0.495 |
|
| 1986 |
Llorens-Cortes C, Gros C, Schwartz JC. Study of endogenous Tyr-Gly-Gly, a putative enkephalin metabolite, in mouse brain: validation of a radioimmunoassay, localisation and effects of peptidase inhibitors. European Journal of Pharmacology. 119: 183-91. PMID 3912194 DOI: 10.1016/0014-2999(85)90294-8 |
0.331 |
|
| 1986 |
Schwartz JC, de la Baume S, Bouthenet ML, Giros B, Gros C, Llorens-Cortes C, Pollard H, Sales N, Solhonne B, Costentin J. [Neuropeptidases responsible for the inactivation of enkephalins and the pharmacology of their inhibitors]. Journal De Pharmacologie. 17: 104-22. PMID 3546953 |
0.449 |
|
| 1986 |
Giros B, Llorens-Cortes C, Gros C, Schwartz JC. The endogenous tripeptide Tyr-Gly-Gly as a possible metabolite of opioid peptides in rat brain: identification, regional distribution, effects of lesions and formation in depolarized slices. Peptides. 7: 669-77. PMID 3532054 DOI: 10.1016/0196-9781(86)90043-4 |
0.565 |
|
| 1986 |
Llorens-Cortes C, Gros C, Schwartz JC. Steady-state level and turnover rate of the tripeptide Tyr-Gly-Gly as indexes of striatal enkephalin release in vivo and their reduction during pentobarbital anesthesia. Proceedings of the National Academy of Sciences of the United States of America. 83: 6226-30. PMID 3526354 DOI: 10.1073/Pnas.83.16.6226 |
0.308 |
|
| 1986 |
Costentin J, Vlaiculescu A, Chaillet P, Ben Natan L, Aveaux D, Schwartz JC. Dissociated effects of inhibitors of enkephalin-metabolising peptidases or naloxone on various nociceptive responses. European Journal of Pharmacology. 123: 37-44. PMID 3519246 DOI: 10.1016/0014-2999(86)90684-9 |
0.524 |
|
| 1986 |
Giros B, Llorens-Cortes C, Gros C, Schwartz JC. The endogenous tripeptide Tyr-Gly-Gly as an extracellular metabolite of enkephalins in rat brain: origin and metabolism. Nida Research Monograph. 75: 271-4. PMID 3123944 |
0.508 |
|
| 1986 |
Martres MP, Sales N, Bouthenet ML, Schwartz JC. Localisation and pharmacological characterisation of D-2 dopamine receptors in rat cerebral neocortex and cerebellum using [125I]iodosulpride. European Journal of Pharmacology. 118: 211-9. PMID 2935411 DOI: 10.1016/0014-2999(85)90131-1 |
0.395 |
|
| 1986 |
Gros C, Solhonne B, Giros B, Pollard H, Salès N, Schwartz JC, Ronco P, Verroust P. Immunohistochemical and subcellular studies of aminopeptidase M localization in rat brain: microvessels and synaptic membranes. Nida Research Monograph. 75: 303-6. PMID 2893270 |
0.455 |
|
| 1986 |
Giros B, Gros C, Solhonne B, Schwartz JC. Characterization of aminopeptidases responsible for inactivating endogenous (Met5)enkephalin in brain slices using peptidase inhibitors and anti-aminopeptidase M antibodies. Molecular Pharmacology. 29: 281-7. PMID 2869404 |
0.486 |
|
| 1986 |
Arrang JM, Schwartz JC, Schunack W. Stereoselectivity of the histamine H3-presynaptic autoreceptor. European Journal of Pharmacology. 117: 109-14. PMID 2417862 DOI: 10.1016/0014-2999(85)90478-9 |
0.444 |
|
| 1986 |
Schwartz J, Costentin J, Lecomte J. Schwartz et al. reply Trends in Pharmacological Sciences. 7: 89-90. DOI: 10.1016/0165-6147(86)90268-3 |
0.435 |
|
| 1986 |
Schwartz J, Arrang J, Garbarg M. Three classes of histamine receptors in brain Trends in Pharmacological Sciences. 7: 24-28. DOI: 10.1016/0165-6147(86)90236-1 |
0.507 |
|
| 1985 |
Vasse M, Protais P, Costentin J, Schwartz JC. Unexpected potentiation by discriminant benzamide derivatives of stereotyped behaviours elicited by dopamine agonists in mice. Naunyn-Schmiedeberg's Archives of Pharmacology. 329: 108-16. PMID 4040215 DOI: 10.1007/Bf00501198 |
0.447 |
|
| 1985 |
Sokoloff P, Redouane K, Brann M, Martres MP, Schwartz JC. 3H-(-)DO 710 discriminates guanine nucleotide sensitive and insensitive dopamine binding sites Naunyn-Schmiedeberg's Archives of Pharmacology. 329: 236-243. PMID 4022135 DOI: 10.1007/Bf00501874 |
0.42 |
|
| 1985 |
Sokoloff P, Brann M, Redouane K, Martres MP, Schwartz JC, Bouthenet ML, Sales N, Mann A, Hamdi P, Wermuth CG, Roy J, Morgat JL. The use of [3H](-)-DO 710 as selective dopaminergic ligand for binding and autoradiographic studies European Journal of Pharmacology. 107: 243-251. PMID 3979426 DOI: 10.1016/0014-2999(85)90064-0 |
0.468 |
|
| 1985 |
Vargas F, Frerot O, Tuong MD, Zuzel K, Rose C, Schwartz JC. Sulfation and desulfation of cerebral cholecystokinin. Annals of the New York Academy of Sciences. 448: 110-20. PMID 3861116 DOI: 10.1111/J.1749-6632.1985.Tb29911.X |
0.305 |
|
| 1985 |
Martres MP, Bouthenet ML, Sales N, Sokoloff P, Schwartz JC. Widespread distribution of brain dopamine receptors evidenced with [125I]iodosulpride, a highly selective ligand. Science (New York, N.Y.). 228: 752-5. PMID 3838821 DOI: 10.1126/Science.3838821 |
0.465 |
|
| 1985 |
Redouane K, Sokoloff P, Schwartz JC, Hamdi P, Mann A, Wermuth CG, Roy J, Morgat JL. Photoaffinity labeling of D-2 dopamine binding subunits from rat striatum, anterior pituitary and olfactory bulb with a new probe, [3H]azidosulpride. Biochemical and Biophysical Research Communications. 130: 1086-92. PMID 3161508 DOI: 10.1016/0006-291X(85)91727-9 |
0.457 |
|
| 1985 |
Bouthenet M, Sales N, Schwartz J. Autoradiographic localisation of3H-apomorphine binding sites in rat brain Naunyn-Schmiedebergs Archives of Pharmacology. 330: 1-8. PMID 2995839 DOI: 10.1007/Bf00586702 |
0.375 |
|
| 1985 |
Arrang JM, Garbarg M, Quach TT, Dam Trung TuongM, Yeramian E, Schwartz JC. Actions of betahistine at histamine receptors in the brain. European Journal of Pharmacology. 111: 73-84. PMID 2990946 DOI: 10.1016/0014-2999(85)90115-3 |
0.502 |
|
| 1985 |
Gros C, Giros B, Schwartz JC. Purification of membrane-bound aminopeptidase from rat brain: identification of aminopeptidase M. Neuropeptides. 5: 485-8. PMID 2860607 DOI: 10.1016/0143-4179(85)90060-5 |
0.529 |
|
| 1985 |
Gros C, Giros B, Llorens C, Malfroy B, Pollard H, Pachot I, Schwartz JC, Mazie JC. Enkephalin metabolism and its inhibition. Biochemical Society Transactions. 13: 47-50. PMID 2860040 DOI: 10.1042/Bst0130047 |
0.494 |
|
| 1985 |
Gros C, Giros B, Schwartz JC. Identification of aminopeptidase M as an enkephalin-inactivating enzyme in rat cerebral membranes. Biochemistry. 24: 2179-85. PMID 2859885 DOI: 10.1021/Bi00330A011 |
0.499 |
|
| 1985 |
Schwartz J, Costentin J, Lecomte J. Pharmacology of enkephalinase inhibitors Trends in Pharmacological Sciences. 6: 472-476. DOI: 10.1016/0165-6147(85)90226-3 |
0.505 |
|
| 1984 |
Llorens-Cortes C, Schwartz JC. Changes in turnover of cerebral monoamines following inhibition of enkephalin metabolism by thiorphan and bestatin. European Journal of Pharmacology. 104: 369-74. PMID 6594244 DOI: 10.1016/0014-2999(84)90415-1 |
0.359 |
|
| 1984 |
Sokoloff P, Martres M, Delandre M, Redouane K, Schwartz J. 3H-domperidone binding sites differ in rat striatum and pituitary Naunyn-Schmiedebergs Archives of Pharmacology. 327: 221-227. PMID 6493362 DOI: 10.1007/Bf00502453 |
0.354 |
|
| 1984 |
Protais P, Bonnet JJ, Costentin J, Schwartz JC. Rat climbing behavior elicited by stimulation of cerebral dopamine receptors. Naunyn-Schmiedeberg's Archives of Pharmacology. 325: 93-101. PMID 6425703 DOI: 10.1007/Bf00506188 |
0.49 |
|
| 1984 |
Martres MP, Sokoloff P, Delandre M, Schwartz JC, Protais P, Costentin J. Selection of dopamine antagonists discriminating various behavioral responses and radioligand binding sites. Naunyn-Schmiedeberg's Archives of Pharmacology. 325: 102-15. PMID 6144046 DOI: 10.1007/Bf00506189 |
0.533 |
|
| 1983 |
Chaillet P, Marçais-Collado H, Costentin J, Yi CC, De La Baume S, Schwartz JC. Inhibition of enkephalin metabolism by, and antinociceptive activity of, bestatin, an aminopeptidase inhibitor. European Journal of Pharmacology. 86: 329-36. PMID 6572590 DOI: 10.1016/0014-2999(83)90181-4 |
0.559 |
|
| 1983 |
de la Baume S, Yi CC, Schwartz JC, Chaillet P, Marcais-Collado H, Costentin J. Participation of both 'enkephalinase' and aminopeptidase activities in the metabolism of endogenous enkephalins. Neuroscience. 8: 143-51. PMID 6300726 DOI: 10.1016/0306-4522(83)90033-7 |
0.399 |
|
| 1982 |
de la Baume S, Gros C, Yi CC, Chaillet P, Marcais-Collado H, Costentin J, Schwartz JC. Selective participation of both "enkephalinase" and aminopeptidase activities in the metabolism of endogenous enkephalins. Life Sciences. 31: 1753-6. PMID 6759827 DOI: 10.1016/0024-3205(82)90202-8 |
0.479 |
|
| 1982 |
Schwartz JC, De La Baume S, Yi CC, Chaillet P, Marcais-Collado H, Costentin J. Enkephalin metabolism in brain and its inhibition. Progress in Neuro-Psychopharmacology & Biological Psychiatry. 6: 665-71. PMID 6298893 DOI: 10.1016/S0278-5846(82)80166-8 |
0.524 |
|
| 1982 |
Quach TT, Rose C, Duchemin AM, Schwartz JC. Glycogenolysis induced by serotonin in brain: identification of a new class of receptor. Nature. 298: 373-5. PMID 6123954 DOI: 10.1038/298373a0 |
0.346 |
|
| 1981 |
Llorens C, Schwartz JC. Enkephalinase activity in rat peripheral organs. European Journal of Pharmacology. 69: 113-6. PMID 7009170 DOI: 10.1016/0014-2999(81)90609-9 |
0.339 |
|
| 1981 |
Schwartz J, Garbarg M, Quach TT. Histamine receptors in brain as targets for tricyclic antidepressants Trends in Pharmacological Sciences. 2: 122-125. DOI: 10.1016/0165-6147(81)90285-6 |
0.472 |
|
| 1980 |
Sokoloff P, Martres M, Schwartz J. 3H-apomorphine labels both dopamine postsynaptic receptors and autoreceptors. Nature. 288: 283-286. PMID 7432527 DOI: 10.1038/288283A0 |
0.496 |
|
| 1980 |
Patey G, de la Baume S, Gros C, Schwartz JC. Ontogenesis of enkephalinergic systems in rat brain: post-natal changes in enkephalin levels, receptors and degrading enzyme activities. Life Sciences. 27: 245-52. PMID 6250001 DOI: 10.1016/0024-3205(80)90144-7 |
0.427 |
|
| 1980 |
Dam Trung Tuong M, Garbarg M, Schwartz JC. Pharmacological specificity of brain histamine H2-receptors differs in intact cells and cell-free preparations. Nature. 287: 548-51. PMID 6106900 DOI: 10.1038/287548A0 |
0.322 |
|
| 1980 |
Guyon A, Roques BP, Guyon F, Foucault A, Perdrisot R, Swerts JP, Schwartz JC. Enkephalin degradation in mouse brain studied by a new H.P.L.C. method: further evidence for the involvement of carboxydipeptidase. Life Sciences. 25: 1605-11. PMID 522617 DOI: 10.1016/0024-3205(79)90444-2 |
0.329 |
|
| 1980 |
Schwartz JC. Minireview: histamine receptors in brain. Life Sciences. 25: 895-911. PMID 41990 DOI: 10.1016/0024-3205(79)90495-8 |
0.507 |
|
| 1979 |
Martres MP, Baudry M, Schwartz JC. Characterization of 3H-domperidone binding on striatal dopamine receptors. Life Sciences. 23: 1781-4. PMID 723450 DOI: 10.1016/0024-3205(78)90108-X |
0.455 |
|
| 1979 |
de la Baume S, Patey G, Marçais H, Protais P, Costentin J, Schwartz JC. Changes in dopamine receptors in mouse striatum following morphine treatments. Life Sciences. 24: 2333-42. PMID 573360 DOI: 10.1016/0024-3205(79)90531-9 |
0.589 |
|
| 1979 |
Gacel G, Fournié-Zaluski MC, Fellion E, Roques BP, Senault B, Lecomte JM, Malfroy B, Swerts JP, Schwartz JC. Conformation and biological activities of hexapeptides related to enkephalins: respective roles of the ammonium and hydroxyl groups of tyrosine. Life Sciences. 24: 725-31. PMID 440018 DOI: 10.1016/0024-3205(79)90354-0 |
0.325 |
|
| 1979 |
Duchemin AM, Quach TT, Rose C, Schwartz JC. Pharmacological characterization of 3H-LSD binding sites in mouse brain in vivo. Life Sciences. 24: 401-9. PMID 431327 DOI: 10.1016/0024-3205(79)90210-8 |
0.408 |
|
| 1979 |
Schwartz J. Opiate receptors on catecholaminergic neurones in brain Trends in Neurosciences. 2: 137-139. DOI: 10.1016/0166-2236(79)90055-9 |
0.431 |
|
| 1978 |
Pollard H, Llorens C, Bonnet JJ, Costentin J, Schwartz JC. Opiate receptors on mesolimbic dopaminergic neurons. Neuroscience Letters. 7: 295-9. PMID 19605129 DOI: 10.1016/0304-3940(78)90216-1 |
0.558 |
|
| 1978 |
Palacios JM, Schwartz JC, Garbarg M. High affinity binding of 3H-histamine in rat brain. European Journal of Pharmacology. 50: 443-4. PMID 699966 DOI: 10.1016/0014-2999(78)90151-6 |
0.364 |
|
| 1978 |
Schwartz JC, Baudry M, Martres MP, Costentin J, Protais P. Increased in vivo binding of 3H-pimozide in mouse striatum following repeated administration of haloperidol. Life Sciences. 23: 1785-9. PMID 569235 DOI: 10.1016/0024-3205(78)90109-1 |
0.564 |
|
| 1978 |
Marcais H, Protais P, Costentin J, Schwartz JC. A gradual score to evaluate the climbing behaviour elicited by apomorphine in mice. Psychopharmacology. 56: 233-4. PMID 417378 DOI: 10.1007/Bf00431856 |
0.442 |
|
| 1978 |
Schwartz JC, Costentin J, Martres MP, Protais P, Baudry M. Modulation of receptor mechanisms in the CNS: hyper- and hyposensitivity to catecholamines. Neuropharmacology. 17: 665-85. PMID 211458 DOI: 10.1016/0028-3908(78)90080-1 |
0.54 |
|
| 1978 |
Quach TT, Rose C, Schwartz JC. [3H]Glycogen hydrolysis in brain slices: responses to neurotransmitters and modulation of noradrenaline receptors. Journal of Neurochemistry. 30: 1335-41. PMID 27582 DOI: 10.1111/j.1471-4159.1978.tb10464.x |
0.346 |
|
| 1977 |
Baudry M, Costentin J, Marcais H, Martres MP, Protais P, Schwartz JC. Decreased responsiveness to low doses of apomorphine after dopamine agonists and the possible involvement of hyposensitivity of dopamine 'autoreceptors'. Neuroscience Letters. 4: 203-7. PMID 19604945 DOI: 10.1016/0304-3940(77)90139-2 |
0.525 |
|
| 1977 |
Martres MP, Costentin J, Baudry M, Marcais H, Protais P, Schwartz JC. Long-term changes in the sensitivity of pre-and postsynaptic dopamine receptors in mouse striatum evidenced by behavioural and biochemical studies. Brain Research. 136: 319-37. PMID 922486 DOI: 10.1016/0006-8993(77)90806-X |
0.554 |
|
| 1977 |
Baudry M, Martres MP, Schwartz JC. In vivo binding of 3H-pimozide in mouse striatum: effects of dopamine agonists and antagonists. Life Sciences. 21: 1163-70. PMID 916813 DOI: 10.1016/0024-3205(77)90116-3 |
0.467 |
|
| 1977 |
Verdière M, Rose C, Schwartz J. Turnover of cerebral histamine in a stressful situation Brain Research. 129: 107-119. PMID 871922 DOI: 10.1016/0006-8993(77)90973-8 |
0.341 |
|
| 1977 |
Costentin J, Marçais H, Protais P, Baudry M, De La Baume S, Martres MP, Schwartz JC. Rapid development of hypersensitivity of striatal dopamine receptors induced by alpha-methylparatyrosine and its prevention by protein synthesis inhibitors. Life Sciences. 21: 307-13. PMID 561281 DOI: 10.1016/0024-3205(77)90510-0 |
0.585 |
|
| 1977 |
Verdiere M, Rose C, Schwartz JC. Synthesis and release of histamine studied on slices from rat hypothalamus. European Journal of Pharmacology. 34: 157-68. PMID 63382 DOI: 10.1016/0014-2999(75)90236-8 |
0.362 |
|
| 1976 |
Schwartz JC. Histamine as a transmitter in brain. Life Sciences. 17: 503-17. PMID 241888 DOI: 10.1016/0024-3205(75)90083-1 |
0.346 |
|
| 1976 |
Audigier Y, Virion A, Schwartz J. Stimulation of cerebral histamine H2 receptors by clonidine. Nature. 262: 307-308. PMID 183124 DOI: 10.1038/262307A0 |
0.447 |
|
| 1975 |
Baudry M, Martres MP, Schwartz JC. H1 and H2 receptors in the histamine-induced accumulation of cyclic AMP in guinea pig brain slices. Nature. 253: 362-4. PMID 234179 DOI: 10.1038/253362A0 |
0.441 |
|
| 1973 |
Pollard H, Bischoff S, Schwartz JC. Increased synthesis and release of 3H-histamine in rat brain by reserpine European Journal of Pharmacology. 24: 399-401. PMID 4128953 DOI: 10.1016/0014-2999(73)90168-4 |
0.375 |
|
| 1972 |
Schwartz JC, Pollard H, Bischoff S, Rehault MC, Verdiere-Sahuque M. Catabolism of 3 H-histamine in the rat brain after intracisternal administration. European Journal of Pharmacology. 16: 326-35. PMID 5132560 DOI: 10.1016/0014-2999(71)90035-5 |
0.392 |
|
| 1969 |
Schwartz JC, Ronnberg AL, Cohen Y, Valette G. Histamine formation in rat stomach: study of regulation mechanisms. European Journal of Pharmacology. 5: 272-8. PMID 5772676 DOI: 10.1016/0014-2999(69)90148-4 |
0.315 |
|
| Show low-probability matches. |